ABOUT NEWS COMPANIES INVESTORS CONTACT INFO@IEQUITYCORP.COM Acquiring Growth in a Green World
About

Established in 2012, iEquity Corp was created to develop companies and projects in the medical cannabis space.

iEquity Corp currently holds controlling interest and retains intellectual properties and contracts in several medical marijuana companies and projects.

Companies

Cannabis Creative Partners, Inc

CBD Drink Co

Kasper Seeding

Medical Cannabis Venture Corp

Medical Greens

MedScience Laboratories

PharmaJanes

Simple Prepay

SK3 Group, Inc

World Pharma Financial

News
iEquity News
iEquity Corp to acquire controlling interest in AVNE
iequity February 23, 2014 at 06:47 PM
iEquity Corp to acquire controlling interest in AVNE
Los Angeles, CA – February 23, 2014 – iEquity Corp today announces that it has signed a definitive agreement to acquire the controlling interest of Aventura Equities, Inc (OTC.PK: AVNE).

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.
iEquity Corp Acquires Controlling Interest in AEGY
iequity May 13, 2013 at 11:00 AM
iEquity Corp Acquires Controlling Interest in AEGY

Los Angeles, CA – May 13, 2013 – iEquity Corp today announces that it has acquired controlling interest of Alternative Energy Partners, Inc (OTC BB: AEGY).

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

iEquity Corp Secures $150M in Financing
iequity April 13, 2013 at 09:43 AM
iEquity Corp Secures $150M in Financing

Los Angeles, CA -- April 3, 2013 -- iEquity Corp today announces that it has secured $150M in financing. iEquity Corp was formed to develop, consult, and arrange financing for various medical cannabis companies. iEquity Corp currently holds controlling interest and intellectual property in several medical cannabis companies.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

Subsidiary News
SK3 Group Announces First Sales of Industry Leading Medical Cannabis Product T-Hydrocan(TM) RMC 40
Sk3 Group, Inc. April 22, 2014 at 06:30 AM
SK3 Group Announces First Sales of Industry Leading Medical Cannabis Product T-Hydrocan(TM) RMC 40
LOS ANGELES, CA--(Marketwired - Apr 22, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO) is pleased to announce that the first bottles of its new medicinal cannabis product, T-Hydrocan™ RMC 40, will be available this Wednesday, April 23, 2014, from Pharmajanes.com, and soon thereafter from collectives which carry the YAK Edibles line of medical marijuana products. The "RMC" designation indicates "refined mixed cannabinoids."

T-Hydrocan™ RMC 40 tablets contain 40 mg. of fully activated (decarboxylated) THC, along with the attendant cannabinoids that are found in the cannabis/hemp source material. The cannabis oils have been thoroughly refined utilizing organic processing materials which have been approved for contact with food, yielding a translucent red or gold colored essential oil containing highly concentrated cannabinoids, terpenes, terpenoids, amino acids, and other refined elements of the essential oil of cannabis.

T-Hydrocan™ RMC 40 is packaged 8 tablets per bottle. The suggested retail price is $35.00 per bottle.

T-Hydrocan™ RMC 40 was developed by Berkeley Bio-Organic Research Laboratories, Inc. and is available through Pharmajanes.com and select dispensaries throughout California. The next product in the T-Hydrocan™ product line will be T-Hydrocan™ Whole Plant 25 tablets and capsules.

"We are pleased to get this product to market so quickly," said Artemus Mayor, President of SK3 Group. "Licensing fees from this product will go straight to the company's bottom line and will give patients a high dosage capsule at an affordable price."

FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease. Use only as directed.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
David Hoye to Join SK3 Group (OTC Pink: SKTO) Board of Directors
Sk3 Group, Inc. April 15, 2014 at 09:30 AM
David Hoye to Join SK3 Group (OTC Pink: SKTO) Board of Directors
LOS ANGELES, CA--(Marketwired - Apr 15, 2014) - David Hoye has been appointed to the Board of Directors of SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO). Hoye is co-founder of Berkeley Bio-Organic Research Laboratories, which was acquired in April of last year.

"I am honored to be asked to take this position," said Hoye. "Over the past year that my group has been working with SK3 Group, I have been very impressed with the skill, competence, and compassion for patients expressed by my new partners. It seems that we now have a perfect union of business and financial acumen combined with science and compassion. I could not have asked for a better situation when I first associated with SK3 Group, and being asked to take an increased role in the overall direction we will be taking as we pioneer this new sector is something that I cherish."

"We are very pleased to have David take an official position on the Board of Directors of our company," said Artemus Mayor, President of SK3 Group, Inc. "David's Berkeley Bio-Organic Research Laboratories was an early acquisition made by SK3 Group after entering the medical marijuana sector. As a result of his expertise, knowledge, and experience, we now have a rapidly expanding line of unique, industry-leading cannabis/hemp-based products and technology that will play an important role in this new sector of medicine. By taking an official position on the Board of SK3 Group, parent company of Berkeley Bio, David will help guide us through the many intricacies of this fascinating and beneficial emerging new world of business and healthcare."

"David's accomplishments in this world are legendary. His book, Cannabis Alchemy, published in 1972, has sold 100,000 copies and was the first scientific book on cannabis technology presented from a consumer's point of view. It introduced the cannabis culture to cannabidiol (CBD), cannabis oil, isomerization, extraction, resin separation, and refinement to pure THC. Amongst many other significant accomplishments, David opened the first new legal dispensary in San Francisco after the passage of Proposition 215, he and his wife Mary Ann founded and run a collective which treats dozens of cancer patients at no cost, and David was a co-founder of Berkeley Bio-Organic Research Laboratories, which has made several groundbreaking discoveries resulting in exciting and beneficial new cannabis/hemp-based healthcare products."

"David's achievements over nearly five decades in cannabis science have made him renowned in the world of cannabis culture," Mayor continued. "His experience, knowledge, and contacts in this arena will be of great benefit as we determine the best path to take in order to provide solid value to our shareholders, and the substantial healthcare benefits of this amazing medicinal plant to the patients who utilize our technology and products."

About SKTO
SK3 Group, Inc. is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 Group brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Watch Yesterday's "Getting Doug with High" Featuring Dominic Monaghan (Star of Lord of the Rings, Lost, and X-Men Origins: Wolverine) on YouTube's Video Podcast Network Featuring SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY)
Sk3 Group, Inc. April 10, 2014 at 11:38 AM
Watch Yesterday's "Getting Doug with High" Featuring Dominic Monaghan (Star of Lord of the Rings, Lost, and X-Men Origins: Wolverine) on YouTube's Video Podcast Network Featuring SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY)
LOS ANGELES, CA--(Marketwired - Apr 10, 2014) - Yesterday's live broadcast of cutting edge and industry leading YouTube based talk show "Getting Doug with High" featured the products and services of title sponsors SK3 Group (OTC Pink: SKTO) (PINKSHEETS: SKTO) and Pharmajanes.com (AEGY).

Watch Doug Benson and actor Dominic Monaghan (Lord of the Rings, Lost, and X-Men Origins Wolverine) as they talk about delivery by PharmaJanes.com and use products available on www.pharmajanes.com here: https://www.youtube.com/watch?v=hBEZPQ1mgtI. Watch closely to catch your very own show specific www.pharmajanes.com discount code!

Recently featured on the front page of Yahoo News, "Getting Doug with High" is comedian Doug Benson's hit Internet show where everyone gets high. Each episode, Doug welcomes a celebrity actor or comedian to smoke live on camera. Then the show begins. Past guests have included Sarah Silverman, Aubrey Plaza, Tommy Chong, Jeff Ross, and many more.

Doug Benson is a working comedian based in Los Angeles who was the star of "Super High Me," "The Marijuana-Logues," and regularly appears on Comedy Central.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

About AEGY
AEGY's PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.


About Video Podcast Network
Video Podcast Network is part of the JASH network and brings the best of comedy podcasting and online talk shows to YouTube. Shows include "Norm Macdonald Live," "The Adam Carolla Show Live," "Positive Push with Brody Stevens," "Earwolf Live," "Getting Doug with High," and more. It is also home of the popular animation series "Animashups."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Be Sure To Catch "Getting Doug with High" on YouTube's Video Podcast Network Featuring the Title Sponsorship, Products, and Services of SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY) Later Today, April 9, 2014, and Get Your Discount Code
Sk3 Group, Inc. April 09, 2014 at 05:20 PM
Be Sure To Catch "Getting Doug with High" on YouTube's Video Podcast Network Featuring the Title Sponsorship, Products, and Services of SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY) Later Today, April 9, 2014, and Get Your Discount Code
LOS ANGELES, CA--(Marketwired - Apr 9, 2014) - Cutting edge and industry leading YouTube based talk show "Getting Doug with High" will feature the products and services of title sponsors SK3 Group (OTC Pink: SKTO)(PINKSHEETS: SKTO) and Pharmajanes.com (AEGY) later today at 4:15pm Pacific Time. Recently featured on the front page of Yahoo News, "Getting Doug with High" is comedian Doug Benson's hit Internet show where everyone gets high. Each episode, Doug welcomes a celebrity actor or comedian to smoke live on camera, and today the smoking will start at 4:20pm. Then the show begins. If you did not catch last week's episode featuring the products and services of SKTO and AEGY, watch it at https://www.youtube.com/watch?v=LiN5CRStTUA. And watch for the secret pharmajanes.com discount code at the end!

Past guests include Sarah Silverman, Aubrey Plaza, Tommy Chong, Jeff Ross, and many more. Doug Benson is a working comedian based in Los Angeles who was the star of "Super High Me," "The Marijuana-Logues," and regularly appears on Comedy Central.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

About AEGY
AEGY's PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.


About Video Podcast Network, LLC
Video Podcast Network is part of the JASH network and brings the best of comedy podcasting and online talk shows to YouTube. Shows include "Norm Macdonald Live," "The Adam Carolla Show Live," "Positive Push with Brody Stevens," "Earwolf Live," "Getting Doug with High," and more. It is also home of the popular animation series "Animashups."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY) Sign Definitive Agreement to Merge
Sk3 Group, Inc. April 04, 2014 at 04:20 PM
SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY) Sign Definitive Agreement to Merge
LOS ANGELES, CA--(Marketwired - Apr 4, 2014) - Alternative Energy Partners, Inc. (OTCQB: AEGY), doing business as PharmaJanes, and SK3 Group (OTC Pink: SKTO) (PINKSHEETS: SKTO), doing business as Medical Greens, announce that their respective Boards of Directors have signed a definitive agreement to merge the two companies for better market efficiencies and to create a single medical marijuana market support company which can qualify for a higher (AMEX, NASDAQ) market listing.

Per the agreement, SKTO and AEGY will merge into a newly formed acquisition company which will integrate the separate operations of both companies. Shareholders of each constituent party to the merger will receive shares of the new holding company, which will succeed to the SEC reporting obligation of AEGY and which will apply for a new trading symbol, a new CUSIP number, and continued electronic trading status with the Depository Trust Company. The final exchange rate for the common shares of AEGY and SKTO will be based on the volume weighted average market value of each company on the effective date, which has not yet been determined.

The previously announced dividend of the shares of AEGY held by SKTO will be accounted for in the merger by treating those shares as held proportionately by the SKTO shareholders as of the effective date. Closing of the proposed merger will require the new holding company to register the shares to be issued in the merger to the shareholders of both AEGY and SKTO.

"We are excited that this merger is completed and we are looking forward to moving ahead in our newly merged form," said SK3 Group President Artemus Mayor. "I am looking forward to working with the AEGY management to integrate both companies to deliver enhanced value to all of our shareholders."

"This merger will enhance our ability to deliver services to our customers across all of our lines of business," said AEGY President Mario Barrera. "The combined entity will take advantage of scale economies and directly aligned business operations and strategy to take the combined business to the next level."

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

About AEGY
AEGY's PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.


Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Watch Yesterday's "Getting Doug With High" With Former SNL Regular Horatio Sanz on YouTube's Video Podcast Network Featuring SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY)
Sk3 Group, Inc. April 03, 2014 at 09:47 AM
Watch Yesterday's "Getting Doug With High" With Former SNL Regular Horatio Sanz on YouTube's Video Podcast Network Featuring SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY)
LOS ANGELES, CA--(Marketwired - Apr 3, 2014) - Yesterday's live broadcast of cutting edge and industry leading YouTube based talk show "Getting Doug with High" featured the products and services of title sponsors SK3 Group (OTC Pink: SKTO) (PINKSHEETS: SKTO) and Pharmajanes.com (OTCBB: AEGY).

Watch Doug Benson and comedian Horatio Sanz (Saturday Night Live 1998-2006 and featured comedic actor and High Times Magazine's "Stoner of the Year 2003) as they talk about delivery by PharmaJanes.com and use their Monarch Vapes vaporizers with oil here: https://www.youtube.com/watch?v=LiN5CRStTUA.

Pharmajanes.com was featured on each of the two prior week's shows, which now have over 180,000 views for the Workaholics cast episode and over 80,000 views for the David Cross episode.

Recently featured on the front page of Yahoo News, "Getting Doug with High" is comedian Doug Benson's hit Internet show where everyone gets high. Each episode, Doug welcomes a celebrity actor or comedian to smoke live on camera. Then the show begins. Past guests have included Sarah Silverman, Aubrey Plaza, Tommy Chong, Jeff Ross, and many more.

Doug Benson is a working comedian based in Los Angeles who was the star of "Super High Me," "The Marijuana-Logues," and regularly appears on Comedy Central.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

About AEGY
AEGY's PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.


About Video Podcast Network
Video Podcast Network is part of the JASH network and brings the best of comedy podcasting and online talk shows to YouTube. Shows include "Norm Macdonald Live," "The Adam Carolla Show Live," "Positive Push with Brody Stevens," "Earwolf Live," "Getting Doug with High," and more. It is also home of the popular animation series "Animashups."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Be Sure to Catch "Getting Doug with High" on YouTube's Video Podcast Network Featuring the Title Sponsorship, Products, and Services of SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY) Later Today
Sk3 Group, Inc. April 02, 2014 at 05:51 PM
Be Sure to Catch "Getting Doug with High" on YouTube's Video Podcast Network Featuring the Title Sponsorship, Products, and Services of SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY) Later Today
LOS ANGELES, CA--(Marketwired - Apr 2, 2014) - Cutting edge and industry leading YouTube based talk show "Getting Doug with High" will feature the products and services of title sponsors SK3 Group (OTC Pink: SKTO) (PINKSHEETS: SKTO) and Pharmajanes.com (OTCQB: AEGY) later today at 4:15pm Pacific Time. Recently featured on the front page of Yahoo News, "Getting Doug with High" is comedian Doug Benson's hit Internet show where everyone gets high. Each episode, Doug welcomes a celebrity actor or comedian to smoke live on camera, and today the smoking will start at 4:20pm. Then the show begins. If you did not catch last week's episode featuring the products and services of SKTO and AEGY, watch it at https://www.youtube.com/watch?v=i4d-F9EWPmQ.

Past guests include Sarah Silverman, Aubrey Plaza, Tommy Chong, Jeff Ross, and many more. Doug Benson is a working comedian based in Los Angeles who was the star of "Super High Me," "The Marijuana-Logues," and regularly appears on Comedy Central.


SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

About AEGY
AEGY's PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.


About Video Podcast Network, LLC
Video Podcast Network is part of the JASH network and brings the best of comedy podcasting and online talk shows to YouTube. Shows include "Norm Macdonald Live," "The Adam Carolla Show Live," "Positive Push with Brody Stevens," "Earwolf Live," "Getting Doug with High," and more. It is also home of the popular animation series "Animashups."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Watch Yesterday's "Getting Doug With High" With David Cross on YouTube's Video Podcast Network Featuring SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY)
Sk3 Group, Inc. March 27, 2014 at 10:28 AM
Watch Yesterday's "Getting Doug With High" With David Cross on YouTube's Video Podcast Network Featuring SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY)
LOS ANGELES, CA--(Marketwired - Mar 27, 2014) - Yesterday's live broadcast of cutting edge and industry leading YouTube based talk show "Getting Doug with High" featured the products and services of title sponsors SK3 Group (OTC Pink: SKTO) (PINKSHEETS: SKTO) and PharmaJanes.com (OTCBB: AEGY).

Watch Doug Benson and comedian David Cross (Mr. Show and Arrested Development) as they talk about delivery by PharmaJanes.com and use their Monarch Vapes vaporizers with oil here: https://www.youtube.com/watch?v=i4d-F9EWPmQ.

Recently featured on the front page of Yahoo News, "Getting Doug with High" is comedian Doug Benson's hit Internet show where everyone gets high. Each episode, Doug welcomes a celebrity actor or comedian to smoke live on camera. Then the show begins. Past guests have included Sarah Silverman, Aubrey Plaza, Tommy Chong, Jeff Ross, and many more.

Doug Benson is a working comedian based in Los Angeles who was the star of "Super High Me," "The Marijuana-Logues," and regularly appears on Comedy Central.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

About AEGY
AEGY's PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.


About Video Podcast Network
Video Podcast Network is part of the JASH network and brings the best of comedy podcasting and online talk shows to YouTube. Shows include "Norm Macdonald Live," "The Adam Carolla Show Live," "Positive Push with Brody Stevens," "Earwolf Live," "Getting Doug with High," and more. It is also home of the popular animation series "Animashups."

FDA Statement

The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Be Sure to Catch "Getting Doug with High" on YouTube's Video Podcast Network Featuring the Title Sponsorship, Products, and Services of SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY) Later Today
AEGY March 26, 2014 at 09:05 AM
Be Sure to Catch "Getting Doug with High" on YouTube's Video Podcast Network Featuring the Title Sponsorship, Products, and Services of SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY) Later Today
LOS ANGELES, CA--(Marketwired - Mar 26, 2014) - Cutting edge and industry leading YouTube based talk show "Getting Doug with High" will feature the products and services of title sponsors SK3 Group (OTC Pink: SKTO) (PINKSHEETS: SKTO) and Pharmajanes.com (AEGY) later today at 4:15pm Pacific Time. Recently featured on the front page of Yahoo News, "Getting Doug with High" is comedian Doug Benson's hit Internet show where everyone gets high. Each episode, Doug welcomes a celebrity actor or comedian to smoke live on camera, and today the smoking will start at 4:20pm. Then the show begins. If you did not catch last week's episode featuring the products and services of SKTO and AEGY, watch it at https://www.youtube.com/watch?v=XO197yn0USA.

Past guests include Sarah Silverman, Aubrey Plaza, Tommy Chong, Jeff Ross, and many more. Doug Benson is a working comedian based in Los Angeles who was the star of "Super High Me," "The Marijuana-Logues," and regularly appears on Comedy Central.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

About AEGY
AEGY's PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.


About Video Podcast Network, LLC
Video Podcast Network is part of the JASH network and brings the best of comedy podcasting and online talk shows to YouTube. Shows include "Norm Macdonald Live," "The Adam Carolla Show Live," "Positive Push with Brody Stevens," "Earwolf Live," "Getting Doug with High," and more. It is also home of the popular animation series "Animashups."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group's Wholesale Managed Collective Portfolio Announces New Distributor in San Francisco Bay Area Expanding Company Product Reach
Sk3 Group, Inc. March 24, 2014 at 09:30 AM
SK3 Group's Wholesale Managed Collective Portfolio Announces New Distributor in San Francisco Bay Area Expanding Company Product Reach
LOS ANGELES, CA--(Marketwired - Mar 24, 2014) - SK3 Group's (OTC Pink: SKTO) (PINKSHEETS: SKTO) Medical Greens subsidiary is pleased to announce that it now has an additional new distributor in the San Francisco Bay Area in California for its wholesale managed collective portfolio. This step increases the reach of its wholesale managed collective portfolio into additional medical cannabis dispensaries and delivery services for its various product lines including: Dharmanol, Canna-Loz Organic Oil, T-Hydro-Can, Yak Capsules, Yeti Honeybud Oilers, Organakoil, Greenie Whole Plant Cookies, Haute Chocolate Instant Drink Mix, and Mocha-juana Instant Drink Mix. This also opens the way for additional expansion of the Pharmajanes.com delivery service.

The total population of the San Francisco Bay Area is over 7.1 million people, making it the second most populous urban area in California after the Greater Los Angeles area, and the fifth largest in the United States.

The Bay Area is where some of the most regulated and politically supportive cities for medical marijuana in California are located, such as San Francisco, Berkeley, and Oakland.

"This is another important addition to our distribution network for our licensed products," said Artemus Mayor, President of SK3 Group. "San Francisco was home to the first public medical cannabis dispensary in the United States, which paved the way for expansion of medical marijuana to where we are today. We are continuing to broaden our distribution network into key markets to facilitate getting medicine to more patients who need our licensed medical cannabis products as we build our brand."

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Watch Yesterday's "Getting Doug With High" With the Cast of Comedy Central's "Workaholics" on YouTube's Video Podcast Network Featuring SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY)
Sk3 Group, Inc. March 20, 2014 at 10:21 AM
Watch Yesterday's "Getting Doug With High" With the Cast of Comedy Central's "Workaholics" on YouTube's Video Podcast Network Featuring SK3 Group (OTC Pink: SKTO) and PharmaJanes.com (OTCQB: AEGY)
LOS ANGELES, CA--(Marketwired - Mar 20, 2014) - Yesterday's live broadcast of cutting edge and industry leading YouTube based talk show "Getting Doug with High" featured the products and services of title sponsors SK3 Group (OTC Pink: SKTO) (PINKSHEETS: SKTO) and Pharmajanes.com (OTCQB: AEGY).

Watch Doug Benson and the cast of hit Comedy Central show "Workaholics" as they talk about delivery by PharmaJanes.com and use their Monarch Vapes pens and oil here: https://www.youtube.com/watch?v=XO197yn0USA.

Recently featured on the front page of Yahoo News, "Getting Doug with High" is comedian Doug Benson's hit Internet show where everyone gets high. Each episode, Doug welcomes a celebrity actor or comedian to smoke live on camera. Then the show begins. Past guests have included Sarah Silverman, Aubrey Plaza, Tommy Chong, Jeff Ross, and many more.

Doug Benson is a working comedian based in Los Angeles who was the star of "Super High Me," "The Marijuana-Logues," and regularly appears on Comedy Central.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

About AEGY
AEGY's PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.

About Video Podcast Network
Video Podcast Network is part of the JASH network and brings the best of comedy podcasting and online talk shows to YouTube. Shows include "Norm Macdonald Live," "The Adam Carolla Show Live," "Positive Push with Brody Stevens," "Earwolf Live," "Getting Doug with High," and more. It is also home of the popular animation series "Animashups."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group's Wholesale Managed Collective Portfolio Announces New Distributor in San Diego County Expanding Company Product Reach
Sk3 Group, Inc. March 20, 2014 at 09:00 AM
SK3 Group's Wholesale Managed Collective Portfolio Announces New Distributor in San Diego County Expanding Company Product Reach
LOS ANGELES, CA--(Marketwired - Mar 20, 2014) - SK3 Group's (OTC Pink: SKTO) (PINKSHEETS: SKTO) Medical Greens subsidiary is pleased to announce that it now has an additional new distributor in San Diego County, California for its wholesale managed collective portfolio. This step increases the reach of its wholesale managed collective portfolio into additional medical cannabis dispensaries and delivery services for its various product lines including: Dharmanol, Canna-Loz Organic Oil, T-Hydro-Can, Yak Capsules, Yeti Honeybud Oilers, Organakoil, Red Diamond Oil, Greenie Whole Plant Cookies, Haute Chocolate Instant Drink Mix, and Mocha-juana Instant Drink Mix, and opens the way for further expansion of the Pharmajanes.com delivery service.

The total population of San Diego County is over 3.1 million people, making it the second most populous county in California after Los Angeles County. The third ranked county is Orange County, where another new distributor was recently announced.

"This is an important addition to our distribution network for our various products," said Artemus Mayor, President of SK3 Group. "We continue to widen our distribution network into key markets to facilitate getting medicine to more patients who need it and building our brand across California."

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group's Wholesale Managed Collective Announces New Distributor in Orange County Expanding Company Product Reach
Sk3 Group, Inc. March 17, 2014 at 07:49 AM
SK3 Group's Wholesale Managed Collective Announces New Distributor in Orange County Expanding Company Product Reach
LOS ANGELES, CA--(Marketwired - Mar 17, 2014) - SK3 Group's (OTC Pink: SKTO) (PINKSHEETS: SKTO) Medical Greens subsidiary is pleased to announce that it has signed an additional new distributor in Orange County, California for its wholesale managed collective portfolio. This step increases the reach of its wholesale managed collective portfolio into additional medical cannabis dispensaries and delivery services for its various product lines including: Dharmanol, Canna-Loz Organic Oil, T-Hydro-Can, Yak Capsules, Yeti Honeybud Oilers, Organakoil, Red Diamond Oil, Greenie Whole Plant Cookies, Haute Chocolate Instant Drink Mix, and Mocha-juana Instant Drink Mix, and opens the way for further expansion of the Pharmajanes.com delivery service.

"This is an important addition to the distribution network for our wholesale managed collective portfolio," said Artemus Mayor, President of SK3 Group. "While continuing development of our product portfolio, we are systematically widening our distribution network in order to facilitate getting medicine to more patients who need it. This latest progress expands our reach into a significant California local market."

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group's Berkeley Bio Organic Research Laboratories Has Developed Cutting Edge Nutritional Supplement, Alzatrex(TM), Targeted to Assist Those With Memory Deficits and to Reduce Brain Fog From MMJ Use
Sk3 Group, Inc. March 11, 2014 at 09:15 AM
SK3 Group's Berkeley Bio Organic Research Laboratories Has Developed Cutting Edge Nutritional Supplement, Alzatrex(TM), Targeted to Assist Those With Memory Deficits and to Reduce Brain Fog From MMJ Use
LOS ANGELES, CA--(Marketwired - Mar 11, 2014) - SK3 Group's (OTC Pink: SKTO) (PINKSHEETS: SKTO) Berkeley Bio Organic Research Laboratories has developed "Alzatrex"™, an herbal supplement that may be taken orally that combines medical cannabis with a proprietary formula of herbal COX-2 inhibitors. Research has shown that ?9-THC, the main active ingredient in medical marijuana, decreases ß-amyloid plaques and neurodegeneration in Alzheimer's disease, and that it is reduced further by the addition of a COX-2 inhibitor. A COX-2 inhibitor is a form of NSAID that is used to reduce pain.

The combination of a COX-2 inhibitor with medical cannabis also prevents marijuana-induced memory problems and "brain fog" or "haze" that is common. Further, as stated in the journal Cell, "These results suggest that the applicability of medical marijuana would be broadened by concurrent inhibition of COX-2." See Cell, Chen et al.: "?9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling", at http://www.cell.com/retrieve/pii/S0092867413013603?cc=y.

Although the Centers for Disease Control and Prevention has estimated that 5 million Americans are living with Alzheimer's disease, and that 83,000 die from the condition every year, a new study has found that nearly half a million elderly Americans likely died from Alzheimer's disease in 2010, which is almost 6 times higher than previous estimates according to a new study released Wednesday. This moves Alzheimer's from the sixth-leading cause of death in the U.S. to the third-leading killer, right behind heart disease and cancer. See Neurology, "Contribution of Alzheimer disease to mortality in the United States" at http://www.neurology.org/content/early/2014/03/05/WNL.0000000000000240.short?sid=fba9c422-3628-4a5c-ad91-7f4bd0bc4e28.

Furthermore, COX inhibitors have been shown to reduce the occurrence of cancers and pre-cancerous growths.

Artemus Mayor, President of SK3 Group, Inc., said, "We see this as an opportunity to help the many people suffering with Alzheimer's disease. Our new Alzatrex™ product will not only help those with Alzheimer's and dementia, but it will also help medical marijuana patients reduce the side-effects of cannabis, mainly the 'brain fog' that is so common. We are using technology to improve the lives of patients."

Alzatrex™ will be available soon in dispensaries and delivery services across California, to start.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group Completes Beta Testing of Broad Use T-Hydrocan(TM) and Prepares for Distribution to Collectives and Pharmajanes.com
Sk3 Group, Inc. March 11, 2014 at 07:45 AM
SK3 Group Completes Beta Testing of Broad Use T-Hydrocan(TM) and Prepares for Distribution to Collectives and Pharmajanes.com
LOS ANGELES, CA--(Marketwired - Mar 12, 2014) - SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO), doing business as Medical Greens, through its subsidiary Berkely Bio-Organic Research Laboratories, has completed beta-testing of the initial offering in its recently announced phyto-cannabinoid product line, T-Hydrocan™. T-Hydrocan™ RMC 40 contains 40 mg. of refined mixed cannabinoids which have been extracted from cannabis flowers utilizing solvents approved for food contact, refined via numerous filtration and separation processes to remove as many of the non-cannabinoid elements as possible, and pressed into a chewable tablet.

Unlike Medical Greens' non-psychoactive Dharmanol™ product line, T-Hydrocan™ RMC 40 contains fully-activated (decarboxylated) THC, producing the classic effects of medical marijuana via an orally-consumed tablet.

"While we are most excited about the possibilities of the non-psychoactive cannabinoids, the great bulk of the research, as well as the majority of the scientific knowledge of the medicinal healing effects ascribed to cannabis medicine, come from research performed on psychoactive THC. Orally-consumed doses of various types and strengths of traditional cannabis extracts have shown substantial efficacy in treating pain, anxiety, insomnia, anorexia, as well as numerous other conditions. T-Hydrocan RMC 40 tablets have been designed to benefit those seeking relief from these, and many other conditions that have been successfully treated with medicinal cannabis," said David Hoye of Berkeley Bio-Organic Research Laboratory.

Each tablet of T-Hydrocan™RMC 40 contains the following ingredients specifically:

1. Microcrystalline cellulose;
2. Magnesium stearate (vegetable source);
3. Sucrose;
4. Dextrin;
5. Natural flavorings;
6. Vitamin C as ascorbic acid (a preservative); and
7. Purified oil of cannabis / hemp containing 40 mg. of refined mixed phyto-cannabinoids.

T-Hydrocan™ RMC 40 tablets will now be packaged and made available to qualified California medical patients through the network of medicinal collectives serviced and managed by Medical Greens, as well as through the Pharmajanes.com ordering platform.
Several other products in the T-Hydrocan™ product line are being prepared for beta-testing and will soon follow the release of T-Hydrocan™ RMC 40. On the other end of the spectrum from the RMC (refined mixed cannabinoids) offering, T-Hydrocan™ Whole Plant, will contain as many of the over 400 natural medicinal elements of the cannabis/hemp plant as possible, removing only the fiber. Many patients have found the "whole plant" approach preferable to eliminating any possible medicinal element that is present in the natural plant when it is processed into an orally ingested medicine.

Following T-Hydrocan™ Whole-Plant will be T-Hydrocan™ Citrolene™ tablets, which will combine the effects of active cannabinoids with those of the natural terpene d-Limonene. This natural medicine, d-Limonene, is found in cannabis/hemp as well as in many other plants. It has relaxing, anti-anxiety, and anti-spasmodic effects, as it binds with the same receptors in the human body as does the benzodiazapines Valium and Xanax, but has been shown to be non-toxic and non-addictive.

"We are pleased to have completed this step in the development process and are looking forward to seeing T-Hydrocan™ RMC-40 tablets available through our managed collectives and Pharmajanes.com within the next 60 days," said Artemus Mayor, President of Medical Greens. "This development demonstrates our commitment to medical cannabis focused products to deliver more of what our patients want when they want it."

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy doing business as Medical Greens™ and focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Correction to Press Release Announcing SK3 Group Agreement to Merge
Sk3 Group, Inc. March 04, 2014 at 04:51 PM
Correction to Press Release Announcing SK3 Group Agreement to Merge
LOS ANGELES, CA--(Marketwired - Mar 4, 2014) - Earlier today Alternative Energy Partners, Inc. (OTCBB: AEGY) (OTCQB: AEGY), doing business as PharmaJanes™, and SK3 Group (OTC Pink: SKTO), doing business as Medical Greens™, announced an agreement to merge. That press release contained an error that the companies wish to correct. The release incorrectly stated the previously announced AEGY dividend as 30 million shares, but the companies had previously released that the dividend amount would be 100 million shares. The companies wish to clarify that 100 million shares is the correct number for that dividend that will be accounted for in the merger. All other aspects of today's release remain accurate as stated.

About PharmaJanes™
PharmaJanes'™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives. PharmaJanes™ is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy doing business as Medical Greens™ and focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
PharmaJanes.com and SK3 Group Announce Agreement to Merge
Sk3 Group, Inc. March 04, 2014 at 09:56 AM
PharmaJanes.com and SK3 Group Announce Agreement to Merge
LOS ANGELES, CA, Mar 04, 2014 (Marketwired via COMTEX) -- Alternative Energy Partners, Inc. (otcqb:AEGY), doing business as PharmaJanes(TM), and SK3 Group (otc pink:SKTO), doing business as Medical Greens(TM), announce that their respective Boards of Directors have agreed in principle to merge the two companies for better market efficiencies and to create a single medical marijuana market support company which can qualify for a higher (AMEX, NASDAQ) market listing. "This merger will allow us to recognize scale economies and to coordinate our operations much better," said SKTO President Artemus Mayor. According to AEGY President Mario Barrera: "This merger should also clear up other issues including the pending dividend, name change, and CUSIP change."

Final terms of the merger are still being worked out and a merger agreement is expected to be signed within the next 30 days, but the basic terms of the agreed merger call for SKTO and AEGY to merge into a newly formed holding company which will integrate the separate operations of both companies. Shareholders of each constituent party to the merger will receive shares of the new holding company, which will succeed to the SEC reporting obligation of AEGY and which will apply for a new trading symbol, a new CUSIP number, and continued electronic trading status with the Depository Trust Company. The final exchange rate for the common shares of AEGY and SKTO will be based on the volume weighted average market value of each company on the record date, which has not yet been determined.

The previously announced dividend of the 30 million shares of AEGY held by SKTO will be accounted for in the merger by treating those shares as held proportionately by the SKTO shareholders as of the record date. Closing of the proposed merger will require the new holding company to register the shares to be issued in the merger to the shareholders of both AEGY and SKTO, and SKTO has retained an independent accounting firm to conduct an audit of its books as the first required step in the registration process. The audit is expected to take approximately thirty days from start to finish, after which the registration statement will be filed for review by the SEC.

The merger agreement also is expected to be completed and signed in the next thirty days at which time more details of the terms and the timing of the merger can be disclosed. As a result of the merger, the Boards of Directors of the two companies will be restructured and combined into a new Board of Directors in the surviving holding company.

"I am thrilled we are consolidating operations for both of these companies under one roof, and I am looking forward to working closely with the SKTO team," said AEGY Chief Technology Officer Frank Gomez. According to SKTO's Dave Hoye: "This could not be a better arrangement for what we have been doing at Berkeley Bio. This will allow us to more effectively deliver our cutting edge products to our patient customers."

About PharmaJanes(TM)
PharmaJanes'(TM) online ordering platform allows authorized medical marijuana patients to order, process and pay for their needs, in a simple, safe and secure ordering and payment interface. Simple Prepay(TM), a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes(TM) menu. PharmaJanes(TM) features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives. PharmaJanes(TM) is the exclusive online marketing platform for Medical Greens(TM), a subsidiary of SKTO.

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy doing business as Medical Greens(TM) and focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group (OTC Pink: SKTO) Is Seeking to Survey Qualified California Medical Marijuana Patients for Its Soon to Be Released Dharmanol Citrolene Capsules, Providing Free Samples for a Limited Time
Sk3 Group, Inc. February 28, 2014 at 08:05 AM
SK3 Group (OTC Pink: SKTO) Is Seeking to Survey Qualified California Medical Marijuana Patients for Its Soon to Be Released Dharmanol Citrolene Capsules, Providing Free Samples for a Limited Time
LOS ANGELES, CA--(Marketwired - Feb 28, 2014) - Medical Greens, a subsidiary of SK3 Group (OTC Pink: SKTO) is seeking qualified California medical marijuana patients to receive a free sample of its new, non-psychoactive medical cannabis product, Dharmanol Citrolene, developed by its Berkeley Bio-Organic Research Laboratory.

Containing many of the medicinal elements of medical marijuana in their non-psychoactive form, Dharmanol Citrolene provides many of the benefits that scientists are ascribing to medical cannabis, without the high associated with eating or smoking marijuana.

Dharmanol Citrolene contains CBD, a non-psychoactive "chemical cousin" to THC, the element in marijuana that makes people high or stoned. In addition, it contains phyto-cannabinoids in their non-psychoactive carboxylate form. It also contains d-limonene, a medicinal element found in cannabis, known as a terpene.

D-limonene has been shown to have a relaxing, anti-anxiety, anti-spasmodic effect. This is because it binds to the same receptors in the human body as do the pharmaceutical synthetics Valium and Xanax. Dharmanol Citrolene contains a healthy dose of organically-sourced d-limonene. Although the d-limonene used in Dharmanol Citrolene is chemically identical to that produced by the cannabis/hemp plant, it is actually sourced from the rind of citrus fruits.

Interestingly, research has shown d-limonene to have many properties that are similar to cannabis in their interaction with cancer. Sloan Kettering Cancer Center lists 19 very promising studies using this powerful natural medicine.

http://www.mskcc.org/cancer-care/herb/d-limonene.

To participate in the Company's survey, an individual must be a medical cannabis patient with a valid physician recommendation and live in the State of California in one of the zip codes currently served by Pharmajanes.com. To see if you qualify, go to the website and check out the section labeled "Dharmanol Citrolene Promotion." Starting this upcoming Wednesday, March 5, 2014, individuals requesting the promotional product during the first 30 days, while supplies last, will receive a 2-pack of the product.

Patients participating in the survey will be asked to complete a short questionnaire about their use of the product which will assist the Company in developing or improving its offerings.

Dharmanol Citrolene will be available for sale soon after that through Pharmajanes and many dispensaries throughout California.

Mr. Artemus Mayor, President of SK3 Group said, "Now that our Pharmajanes site is up and running, and we are filling orders for our Dharmanol product, we are pleased to be initiating distribution for this important product through our Pharmajanes platform. While Dharmanol Citrolene will only be available to participants in the promotion for the next several weeks, we intend to have the product available to all qualified patients soon, either through our Pharmajanes platform, or through their local dispensary."

About AEGY
PharmaJanes™ is an online ordering platform allowing medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes also is the exclusive online marketing platform for Medical Greens, a subsidiary of SK3 Group, Inc. (OTC Pink: SKTO).

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group Announces Clarification Regarding Press Release From Aventura Equities Dated February 26, 2014
Sk3 Group, Inc. February 27, 2014 at 09:44 AM
SK3 Group Announces Clarification Regarding Press Release From Aventura Equities Dated February 26, 2014
LOS ANGELES, CA--(Marketwired - Feb 27, 2014) - SK3 Group (OTC Pink: SKTO) wishes to clarify certain statements made by Aventura Equities, Inc. ("Aventura") in its press release dated February 26, 2014 ("the Aventura Equities Release").

We have the utmost respect for our business partners at Aventura Equities. However, the Aventura Equities Release was made by the management of Aventura Equities without any prior notice, involvement, or approval of SKTO's management, which could have made the release more clear had it been obtained in advance.

Aventura has not acquired Berkeley Bio-Organic Research Laboratory ("Berkeley Bio"). Berkeley Bio remains a wholly-owned subsidiary of SKTO. In addition, although the transaction referenced resulted in Aventura receiving the rights to the intellectual property in the proprietary technology, processes, formulations, and marks of Berkeley Bio that have already been developed, SKTO remains, and will remain, the exclusive licensee of such intellectual property. The announced agreement/transfer does not permit Aventura to license others to use this intellectual property. In addition, the agreement announced by Aventura Equities does not cover future intellectual property developed by Berkeley Bio which will inure to the benefit of SKTO unless otherwise agreed. We have become aware of incorrect speculation that somehow this announcement impinges upon the rights of SKTO to its use of the Berkeley Bio technology, and that is simply incorrect.

"We continue to be a part of the SKTO family, and remain pleased that we are," said Berkeley Bio-Organic Research Laboratory Director David Hoye. "We remain a subsidiary company of SKTO and SKTO continues to be the sole and exclusive licensee of the proprietary technology, processes, and formulations developed by Berkeley Bio, and we look forward to remaining so for the long term. I would not be involved if it were otherwise."

About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
PharmaJanes, in Affiliation With Medical Greens Announces Expanded Delivery Service Area
AEGY February 20, 2014 at 09:39 AM
PharmaJanes, in Affiliation With Medical Greens Announces Expanded Delivery Service Area
LOS ANGELES, CA--(Marketwired - Feb 20, 2014) - Alternative Energy Partners (OTCBB: AEGY) (OTCQB: AEGY), doing business as PharmaJanes™ ("the Company"), working in conjunction with its partner, SK3 Group (OTC Pink: SKTO), is pleased to announce that its e-commerce order servicing platform (www.PharmaJanes.com), has expanded its delivery service area to include additional zip code areas in California.

PharmaJanes™ facilitates enrollment of medical marijuana patients in its exclusive network of dispensaries by processing and verifying patients' applications in accordance with California state law requirements. PharmaJanes™ then routes the orders to its exclusive non-profit collectives, which then process and deliver the orders to patients. Upon verification and completion of the application process, patients have access to all medical cannabis products available on the PharmaJanes™ menu for ordering and delivery. PharmaJanes™ features products produced by master growers, and products licensed by SK3 Group, Inc. (OTC Pink: SKTO) to SK3's wholesale managed collectives.

The following zip codes are now within the delivery service area:

90004-06 Wilshire
90010 Wilshire
90015 Los Angeles
90019-20 Wilshire
90021-24 Westwood LA
90028-38 Hollywood
90039 & 90049 Brentwood
90040-48 Hollywood
90050-68 Hollywood
90070 Wilshire
90075-76 Wilshire
90077 Bel-Air
90209-13 Beverly Hills
90291 Santa Monica
90401-11 Santa Monica
91001 Pasadena
91011 Pasadena
91020 Glendale
91046 Glendale
91101-08 Pasadena
91201-10 Glendale
91214 Glendale
91303-09 Canoga Park
91311-16 Los Angeles
91324-25 Northridge
91327-39 Northridge
91343-49 LA Hills (Mission and North Hills)
91352-53 Sun Valley
91356-57 Tarzana
91364-71 Woodland Hills
91393-94 Granada Hills
91501-91510 Burbank
91521-91523 Burbank
91526 Burbank
91393-91618 Los Angeles

Patients outside of the current zip code areas listed above are also encouraged to sign up now on the PharmaJanes.com web site to be verified so the roll-out can be expanded efficiently into areas that will service the most patients.

"With this expansion in the delivery service area, we are fulfilling the promise of PharmaJanes™," said AEGY CEO Mario Barrera. "We are committed to expanding our service areas to other areas in California soon so we can reach more medical cannabis patients, and increase the functionality of our ordering platform to enhance the patient's and our collectives' purchase and sale experience."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About AEGY
PharmaJanes™ is an online and smartphone ordering platform allowing medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for SK3 Group, Inc.'s (OTC Pink: SKTO) Medical Greens subsidiary.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group's Medical Greens Is Pleased to Announce That the First Bottles of Dharmanol(TM) Are Shipping and Will Be Immediately Available on www.pharmajanes.com Among Other Places
Sk3 Group, Inc. February 14, 2014 at 07:01 PM
SK3 Group's Medical Greens Is Pleased to Announce That the First Bottles of Dharmanol(TM) Are Shipping and Will Be Immediately Available on www.pharmajanes.com Among Other Places
LOS ANGELES, CA--(Marketwired - Feb 14, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens is pleased to announce that the first bottles of Dharmanol™ Whole Plant tablets, for which Medical Greens has the exclusive license, are shipping today. Dharmanol™ is a medical cannabis-based supplement that contains all of the natural elements of the cannabis/hemp plant that are thought to promote healing, with the exception of THC, the molecule which is responsible for the psychoactive effect -- or "high" -- of marijuana.

Dharmanol™, developed by David Hoye and Dr. Charles Apel of Berkeley Bio-Organic Research Laboratories, contains under .03% THC, less than many hemp-based health products that are sold at stores such as Costco and Walgreens. But it contains 10 mg. of the non-psychoactive phyto-cannabinoids that are present in hemp/cannabis, and are thought to contribute to the myriad of mechanisms that many university-level scientific studies have shown to be responsible for the remarkable healing power of medical marijuana.

Dharmanol™ tablets will be available soon in California through AEGY's www.pharmajanes.com delivery service and select medicinal marijuana dispensaries.

Dharmanol™ is sold in a bottle of 8 tablets. The suggested retail price for a bottle is $25.00. Each tablet contains 5 mg. cannabidiol (CBD), 5 mg. of non-psychoactive mixed carboxylates of the primary cannabinoids, 5 mg. of mixed separated terpenes and terpenoids of cannabis/hemp, 25 mg. of organic cold-pressed hemp oil, and 25 mg. of vitamin C (ascorbic acid as a preservative).

Dharmanol Citrolene™ will be released shortly. This formulation combines the phyto-cannabinoid formula found in Dharmanol™ with a substantial dose of the terpene d-Limonene. D-Limonene is found in cannabis/hemp, but also present in the rinds of certain citrus fruits. D-Limonene has been shown to bind with the same receptors as benzodiazapines such as Valium and Xanax, producing a pronounced relaxing and anti-spasmodic effect, without the negative side effects that many attribute to the synthetic pharmaceuticals.

"We are pleased to be able to start delivering this important product to market through our distribution network of dispensaries and our related web-based delivery service www.pharmajanes.com," said Artemus Mayor, President of SK3 Group, Inc. "These products are industry leading and will allow us to deliver the health benefits of medical marijuana to more patients who will not have to worry about feeling 'high' after their use. These products will contribute directly to our topline revenue growth."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
PharmaJanes.com, Operated in Conjunction With SK3 Group, Announces Ongoing Delivery From Collectives to Patient
Sk3 Group, Inc. February 11, 2014 at 10:36 AM
PharmaJanes.com, Operated in Conjunction With SK3 Group, Announces Ongoing Delivery From Collectives to Patient
LOS ANGELES, CA--(Marketwired - Feb 11, 2014) - Alternative Energy Partners, Inc. (OTCQB: AEGY), doing business as PharmaJanes™ ("the Company"), working in conjunction with its partner, SK3 Group (OTC Pink: SKTO), is pleased to announce that its e-commerce order servicing platform at http://www.PharmaJanes.com, is fully operational and continues to route orders to the exclusive non-profit collectives managed by SKTO, and that patients have received their completed orders in the initial roll-out service areas in the San Fernando Valley in Los Angeles.

Zip codes in the initial roll-out service area include:

91303-09
91311-18
91323-25
91327-39
91343-49
91352-53
91356-57
91363-71
91373-75
91378-79
91393-91618

Medical cannabis patients within the current service area can sign up, submit their doctor's recommendations and drivers' licenses to be verified, log in, and place their orders, all on the PharmaJanes.com site. Expansion of the service area into other parts of metropolitan Los Angeles and then into the rest of California will occur gradually over the next few weeks.

Patients outside of the current roll-out zip code areas listed above are also encouraged to sign up now on the web site to be verified so the roll-out can be expanded efficiently into areas that will service the most patients.

"We are pleased that we have been as successful as we have in the short time since our initial rollout last week," said AEGY CEO Mario Barrera. "We are looking forward to making steady progress in expanding our order and delivery areas and to expanding functionality and enhancing the consumer experience on the site. Go to www.pharmajanes.com to see our progress and to register as a user if you qualify."

About PharmaJanes™
PharmaJanes™ provides a technology platform that facilitates patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications. In addition, PharmaJanes™ routes customer orders to its exclusive non-profit collectives, which then process and deliver the orders to patients in their homes. Upon completion of verification, patients have access to all medical cannabis products available on the PharmaJanes™ menu. PharmaJanes™ features products produced by master growers, and products licensed by SKTO to its wholesale managed collectives.

PharmaJanes™ online ordering platform allows authorized medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay™, a separate division of AEGY, is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes™ also is the exclusive online marketing platform for Medical Greens™, a subsidiary of SKTO.


About SKTO
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Medical Greens Announces Launch of Janes Card Loyalty and Payment Card
Sk3 Group, Inc. January 31, 2014 at 12:55 PM
Medical Greens Announces Launch of Janes Card Loyalty and Payment Card
LOS ANGELES, CA--(Marketwired - Jan 31, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has officially launched its Janes Card™ (www.janescard.com) benefits and payment card. The Janes Card™ is a universal benefits-based prepaid card along with a payment solution and rewards program that is intended to build customer loyalty for all retailers that accept it throughout California. The card has an upscale look and feel, and will be distributed by the Company directly in a large-scale marketing effort. Customers will be able to update their Janes Card™ account online or through a dedicated telephone number, much as they are currently able to do with more traditional credit card and benefits programs. The card is being rolled out in California first, with a goal of a national rollout in short order. The Company is now allowing retailers to sign up as vendors.

"Achieving this milestone is an important accomplishment for the Company. The Janes Card™ will facilitate in-network retailers in receiving payments, building important data from which targeted marketing can be created, developing brand loyalty among customers, and otherwise making it easier for retailers and their customers to transact business," said Company President Artemus Mayor. "The loyalty program, whereby consumers will be able to earn points for their transactions and redeem them for discounts or other loyalty based rewards, is revolutionary in this business and we are confident that it will transform the way patients purchase their medication. The Janes Card is an integral component of our related online program at www.pharmajanes.com, allowing patients to order and receive their medication from the comfort of their own home and receive credit for it toward future purchases, while assisting retailers in targeting their product offerings."

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
PharmaJanes Announces Launch of Website Connecting Collectives With Patients in California
AEGY January 31, 2014 at 09:42 AM
PharmaJanes Announces Launch of Website Connecting Collectives With Patients in California
LOS ANGELES, CA, Jan 31, 2014 (eTeligis.com via COMTEX) LOS ANGELES, CA via eTeligis - Alternative Energy Partners (OTCBB: AEGY) (OTCQB: AEGY), known as PharmaJanes ("the Company"), is pleased to announce that PharmaJanes.com, the e-commerce servicing platform, is now open for new patient enrollment.PharmaJanes will first begin servicing parts of metropolitan Southern California, and thereafter will expand throughout California in phases.At the appropriate time, PharmaJanes intends to roll out nationwide.

PharmaJanes will facilitate patient enrollment in its exclusive network of dispensaries by processing and verifying patients' applications.In addition, PharmaJanes will route the orders to its exclusive non-profit collectives, which then will process and deliver the orders to patients.Upon completion of verification, patients will have access to all medical cannabis products available on the PharmaJanes menu.PharmaJanes will feature products produced by master growers, and products licensed by SK3 Group, Inc. (OTC Pink: SKTO) to SK3's wholesale managed collectives.

"I am thrilled that we met our announced milestone of launching PharmaJanes.com in January and I am looking forward to seeing the start of enrollment of new patients," said Frank Gomez, Chief Technology Officer of PharmaJanes."By bringing technology to bear on the medical cannabis industry, PharmaJanes marks the beginning of a new era of simplified and streamlined access to medicine by patients from the comfort of their own homes.We are expecting this to be a solid growth engine for the company and to revolutionize the way medical cannabis is delivered to patients."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About AEGY
PharmaJanes is an online and smartphone ordering platform allowing medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes also is the exclusive online marketing platform for SK3 Group, Inc.'s (OTC Pink: SKTO) Medical Greens.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Medical Greens to Become Exclusive Distributor of Monarch Vaporizer Pens via PharmaJanes.com and Through Its Affiliated Dispensaries
Sk3 Group, Inc. January 29, 2014 at 10:59 AM
Medical Greens to Become Exclusive Distributor of Monarch Vaporizer Pens via PharmaJanes.com and Through Its Affiliated Dispensaries
LOS ANGELES, CA--(Marketwired - Jan 29, 2014) - SK3 Group, Inc.'s (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has signed an exclusive distribution agreement for the Monarch Vaporizer from Monarch Vapes, a provider of portable personal vaporizers.

The Monarch vape pen is very easy to use by simply pushing the button and inhaling. A well-measured dose of vapor is dispensed automatically. The pen itself is easily re-energized with the included USB charger and has a particularly long battery life. Each cartridge contains upwards of 100 inhalations, and is then easily replaced with another pre-filled replacement cartridge, which will be available from PharmaJanes.com and other California medical marijuana dispensaries.

The Monarch Vaporizer provides the versatility of oil while allowing users to get the benefits of E-juice, a liquid that is commonly vaporized when using an e-cigarette. It is simple, sleek, discreet, and is manufactured with uncompromising quality. Monarch's approach allows users and patients to vaporize whenever and wherever without the judgment of others.

Monarch is in discussions to team up with other companies in order to introduce vaporizable products for the medical cannabis market.

In a 2006 study, researchers at Leiden University in the Netherlands compared vaporization to smoking pure THC and found that, "Our results show that a safe and effective cannabinoid delivery system seems to be available to patients. The final pulmonal uptake of THC is comparable to the smoking of cannabis, while avoiding the respiratory disadvantages of smoking."

Through this deal, Medical Greens is capitalizing on the wave of portable personal vape pens and the growth of vaporizing in general becoming an important accessory for a growing number of Americans.

"We are pleased to sign this exclusive distribution agreement with Monarch Vapes. The e-cigarette market is growing at a tremendous rate, and it is a product with direct applicability to the medical cannabis market," said Artemus Mayor, President of SK3 Group, Inc. "As the size of the e-cigarette market roughly doubled each year for the past several years, we expect similar growth in the medical cannabis vaporizer market and this is an opportunity to utilize the same technology to provide safer and more effective access for cannabis patients to medicate."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group's Medical Greens Signs Management Agreement With Medical Marijuana Logistics Company to Provide Door-to-Door Product Delivery Safely and on Time
Sk3 Group, Inc. January 24, 2014 at 10:25 AM
SK3 Group's Medical Greens Signs Management Agreement With Medical Marijuana Logistics Company to Provide Door-to-Door Product Delivery Safely and on Time
LOS ANGELES, CA--(Marketwired - Jan 24, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it has signed a new management agreement with a medical marijuana-focused logistics company that will be providing secure, timely, and customer-focused door-to-door delivery of medical marijuana products to dispensaries across the entire state of California.

"We are pleased to announce this new channel for our wholesale managed collectives to deliver licensed products to dispensaries statewide," said Artemus Mayor, President of SK3 Group. "This agreement will simplify the logistics of getting our products from source to destination in a timely manner. It also will provide the solid infrastructure to allow our wholesale managed collectives to increase their reach into more dispensaries across the state. This step is a necessary precursor to the PharmaJanes.com website going live later this month because we will also utilize the services of this group under our management agreement with AEGY."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Medical Greens (SKTO) Announces New Topical Medical Cannabis Product Line Topikoil(TM)
Sk3 Group, Inc. January 13, 2014 at 02:16 AM
Medical Greens (SKTO) Announces New Topical Medical Cannabis Product Line Topikoil(TM)
LOS ANGELES, CA--(Marketwired - Jan 13, 2014) - SK3 Group, Inc.'s (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that Berkeley Bio-Organic Research Laboratories is seeking participants to test their new proprietary cannabinoid-based skin care products -- Dharmanol™ Topikoil™, and T-Hydrocan™ Topikoil™.

Numerous scientific studies, as well as a host of anecdotal evidence, have shown that phyto-cannabinoids, and other elements of cannabis / hemp, are active against various types of skin disease. Research by Manuel Guzman at Complutense University in Madrid, Spain has shown that cannabinoids decreased cancer cell proliferation and spreading, decreased density of blood vessels that provide nutrients to tumors, increased cancer cell death, and inhibited tumor-cell metastatic spreading into nearby organs. Much anecdotal evidence on the internet and elsewhere has shown that cannabis oil, when placed on a wart, mole, discoloration, or other growth, can cause numerous types of skin imperfections to simply disappear in just a few weeks with daily treatment.

Berkeley Bio will be testing two types of its proprietary Topikoil™. T-Hydrocan™ Topikoil™ will be made with a substantial dose of whole-plant cannabis extract containing fully activated (decarboxylated) cannabinoids, as well as a wide array of terpenes, terpenoids, and other steam-soluble elements of cannabis / hemp. Dharmanol™ Topikoil™ contains non-psychoactive CBD (cannabidiol) and a wide array of other non-psychoactive cannabinoids from cannabis / hemp.

While the initial testing and rollout will focus on medical cannabis patients in California, the Company intends to roll out Dharmanol™ Topikoil™ nationwide based on the applicable regulations of each state and the US Government.

Those wishing to participate will be provided with several different topical preparations (lotions / salves) and will be required to live in California and keep accurate records, including taking before and after pictures. The testing will begin in one to two months. To sign up, please email your contact information to trials@medicalgreens.com.

"We are very pleased to be announcing these new products," said Artemus Mayor, President of the Company. "Research has shown very significant effectiveness of medical cannabis against a wide variety of skin ailments, and the stories on the Internet of people casually treating skin imperfections with cannabis topicals abound. Not only is this product chemically different than other similar products on the market, but our new products will have consistent, measurable medical cannabis content that should lead to more effective and targeted dosing. Adding this new delivery system to our Dharmanol™ line of products will substantially increase our market reach into new areas, directly benefiting our bottom line. In addition, our experience with these new products will assist in our development of an extended release transdermal patch product as well as other products."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Medical Greens (SKTO) Announces Licensing of Proprietary Cryo-Extraction Technique for Extracting Non-Psychoactive Cannabinoids
Sk3 Group, Inc. January 10, 2014 at 04:52 PM
Medical Greens (SKTO) Announces Licensing of Proprietary Cryo-Extraction Technique for Extracting Non-Psychoactive Cannabinoids
LOS ANGELES, CA--(Marketwired - Jan 10, 2014) - SK3 Group, Inc (OTC Pink: SKTO) is pleased to announce that it has completed the licensing agreements between Berkeley Bio-Organic Research Laboratories, LLC and its managed wholesale collectives to produce non-psychoactive mixed cannabinoid carboxylates (Dharmanol™). The licensing agreement covers the proprietary methods developed by Berkeley Bio -- known as cryo-extraction -- used to extract the cannabinoids and preserve them in their non-psychoactive state.

"We are happy to have put together more of the elements necessary to fill the large demand anticipated for our Dharmanol™ product line," said Artemus Mayor, President of SK3 Group. "Dr. Charles Apel and David Hoye have developed a unique technique for extracting the non-psychoactive but effective components of cannabis that we believe will prove to be the key to bringing an entirely new dimension to the field of nutritional supplements in the United States and greater access to the beneficial effects of medical marijuana."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Medical Greens (SKTO) Signs Management Agreement With Medical Cannabis Growers With Aggregate of Over 12,000 Square Feet of Indoor Cultivation Space in California
Sk3 Group, Inc. January 08, 2014 at 12:44 PM
Medical Greens (SKTO) Signs Management Agreement With Medical Cannabis Growers With Aggregate of Over 12,000 Square Feet of Indoor Cultivation Space in California
LOS ANGELES, CA--(Marketwired - Jan 8, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") announces it has signed a new management contract with medical marijuana growers that have an aggregate of over 12,000 square feet of indoor cultivation in California, in full compliance with state medical marijuana laws and guidelines.

These managed medical cannabis growers are currently in the process of switching to cultivating non-psychoactive strains of medical marijuana that are high in the non-psychoactive cannabinoid Cannabidiol (commonly abbreviated CBD). These non-psychoactive high-CBD strains are primarily used for medicinal purposes.

This agreement provides an exclusive supply of high-CBD raw materials that is a key ingredient in various products that the Company has licensed to its Wholesale Managed Collectives.

Mr. Artemus Mayor, President of the Company, said, "We believe that the market for non-psychoactive medical marijuana products is many times the size of the market for the highly psychoactive medical marijuana products that are currently available. With the increasing acceptance of medical marijuana around the US, the number of medical marijuana patients will grow significantly, increasing demand for the non-psychoactive cannabinoid and CBD products that our licensees produce."

FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SKTO's Medical Greens Announces Start of Distribution of Dharmanol(TM)
Sk3 Group, Inc. December 13, 2013 at 02:23 PM
SKTO's Medical Greens Announces Start of Distribution of Dharmanol(TM)
LOS ANGELES, CA--(Marketwired - Dec 13, 2013) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens is pleased to announce that the first batch of Dharmanol™ has been manufactured and is ready to be rolled out for California distribution.

Dharmanol™ (pronounced DAR-mah-nol) will be available in two forms: low-dose, non-psychoactive tablets and high-doses directed to cancer.

The low-dose, non-psychoactive tablets can be taken daily as a nutritional supplement to stimulate the endo-cannabinoid system, an internal system which controls and regulates many other bodily systems such as immune response. Much research has shown that there is substantial medicinal benefit in "stimulating" a compromised endo-cannabinoid system with cannabinoids, causing the other systems to work as they should.

At the opposite end of the spectrum is using Dharmanol™ for cancer. Very large doses can be taken daily with no psychoactive effects. On observing the spectacular results that patients are receiving with standard Simpson therapy, most scientists studying cannabis medicine agree that if the dose could be increased ten or a hundred times, its already substantial efficacy will be greatly increased. Now this is possible thanks to the removal of the "high" from the cannabinoids in the production of Dharmanol™.

These tablets contain an array of the most beneficial non-psychoactive cannabinoids. Each tablet will contain 5 mg. of CBD, 5 mg. of mixed cannabinoids in their non-psychoactive form (known as mixed carboxylates) and 5 mg. of a steam-distilled mixture of the natural terpenes and terpenoids found in cannabis and hemp. The terpene element is thought to be responsible for the increased medicinal efficacy of "whole plant" cannabis preparations. The specific recipe is proprietary to Medical Greens.

"These products are game changers for patients," said SKTO President Artemus Mayor. "Now patients can accurately regulate their dosing with medication, without any worry of the psychoactive effects, or high, that is the natural byproduct of existing products on the market. We are fortunate that our team has been among the first to be able to enhance the consumer, and patient, experience in this manner."

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease. Use only as directed.
SKTO's Medical Greens Announces Rollout of Revolutionary Cannabis Payment Solution and Loyalty Program
Sk3 Group, Inc. December 05, 2013 at 09:20 AM
SKTO's Medical Greens Announces Rollout of Revolutionary Cannabis Payment Solution and Loyalty Program

LOS ANGELES, CA--(Marketwired - Dec 5, 2013) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens ("the Company") is pleased to announce that it will begin rolling out the Janes Card™ (www.janescard.com) in January 2014. The Janes Card™ is a universal loyalty-based card along with a payment solution for members for medical cannabis collectives and dispensaries throughout California. The card will have an upscale look and feel, and will be distributed by the Company directly as well as through collectives/dispensaries and doctors' offices throughout the state. Customers will be able to update their Janes Card™ account online or through a dedicated telephone number, much as they are currently able to do with more traditional credit card and loyalty programs. The Company expects a nationwide rollout sometime in the first half of 2014.

"We are pleased to deliver on this program just after the start of the New Year. The Janes Card™ will facilitate collectives receiving payments, build important data on their customer base from which targeted marketing can be created, develop brand loyalty among customers, and otherwise make it easier for collectives and their patients to transact business," said Company President Artemus Mayor. "The loyalty program, whereby consumers will be able to earn points for their transactions and redeem them for discounts or other loyalty based rewards, is revolutionary in this business and we are confident that it will transform the way patients purchase their medication. We are also excited about our partners in this venture, who are individuals with decades of experience in the payments processing and loyalty program business. We are looking forward to reporting more on this exciting development in the coming months."

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SKTO's Medical Greens Announces New Distribution Agreement Taking Total Market Presence to Over 400 California Collectives
Sk3 Group, Inc. November 25, 2013 at 12:11 PM
SKTO's Medical Greens Announces New Distribution Agreement Taking Total Market Presence to Over 400 California Collectives

LOS ANGELES, CA--(Marketwired - Nov 25, 2013) - SK3 Group, Inc's (OTC Pink: SKTO) ("the Company") subsidiary Medical Greens is pleased to announce that its managed wholesale collectives portfolio has reached a new distribution agreement for the sale of the Company's products in over 400 collectives throughout California, including: Dharmanol, Canna-Loz Organic Oil, T-Hydro-Can, Yak Capsules, Yeti Honeybud Oilers, Organakoil, Red Diamond Oil, Greenie Whole Plant Cookies, Haute Chocolate Instant Drink Mix, and Mocha-juana Instant Drink Mix.

"This marks an important milestone for the growth of the company," said President Artemus Mayor. "This kind of growth is a testament to the success of our prior strategic moves and the efforts of our sales force. As we broaden the distribution of our products, we are also seeking to deepen it so watch for similar future announcements."

About SK3 SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Medical Greens Announces Development of New T-Hydrocan Medical Cannabis Product Line
Sk3 Group, Inc. November 25, 2013 at 11:06 AM
Medical Greens Announces Development of New T-Hydrocan Medical Cannabis Product Line

LOS ANGELES, CA, Nov 25, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc.'s (OTC Pink: SKTO) subsidiary Medical Greens announces its newest product, T-Hydrocan(TM), a new medicinal cannabis product line. While the focus of SK3's Berkeley Bio's endeavors lies in the development of potential treatments for cancer utilizing non-psychoactive elements of the cannabis/hemp plant, as reflected in the recently-announced Dharmanol(TM) product line, many patients have found considerable benefit from oral administration of THC, the psychoactive element found in the cannabis / hemp plant, when used to treat a wide variety of medical conditions.

A synthetic version of THC, Marinol(TM) has been available by prescription for many years, and is prescribed to remediate the pain and nausea from cancer and the side effects of radiation and chemotherapy. Interestingly, Marinol(TM) is routinely prescribed to cancer patients, and those who also have access to similar natural cannabis products greatly prefer the natural products over the synthetic pharmaceuticals.

T-Hydrocan(TM) tablets contain the psychoactive element THC, as well as the complete array of cannabinoids that are naturally present in the cannabis / hemp plant. In addition to the cannabinoids, T-Hydrocan(TM) tablets contain a steam-distilled extract of cannabis / hemp, containing the natural terpenes and terpenoids which work synergistically with the cannabinoids.

Several different versions of T-Hydrocan(TM) will be offered, adjusting the basic T-Hydrocan(TM) formula for different applications. T-Hydrocan(TM) Whole-Plant(TM) will contain psychoactive, decarboxylated THC, as well as the entire array of related medicinal elements found in the cannabis / hemp plant. T-Hydrocan(TM) Citrolene(TM) will contain a healthy dose of the terpene d-Limonene, which attaches to the same receptors as do tranquilizers such as Valium and Xanax, adding a natural relaxing element to the medicine. T-Hydrocan -- CBD(TM) will add an amount of CBD equal to the THC.

The T-Hydrocan(TM) line of cannabis-based medicinals will be available through the dispensaries and collectives that have partnered with Medical Greens' wholesale managed collectives.

"We are pleased to add this new product to the arsenal of products available through Medical Greens to fight cancer and we look forward to adding many more," said President Artemus Mayor. "We expect this product to contribute significantly to the growth of the Company as it meets this underserved market."

FDA Statement The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

About SK3SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SK3 Group, Inc. Announces Preliminary Earnings for the Third Quarter, 2013
Sk3 Group, Inc. October 31, 2013 at 07:56 PM
SK3 Group, Inc. Announces Preliminary Earnings for the Third Quarter, 2013
Los Angeles, CA -- (October 31, 2013) - SK3 Group, Inc. (OTC Pink: SKTO)(the “Company”) today announced that it has completed its preliminary consolidated financial statements for the quarter ended September 30, 2013. The financial reports are now being reviewed by its outside financial and legal advisors for inclusion in the quarterly report to OTC Markets, due by November 15, 2013.

On a consolidated basis the Company with its subsidiaries, will be reporting approximate revenue and deferred revenue in excess of $13,000,000 for the quarter ending September 30, 2013 compared to $12.996 million for the quarter ending June 30, 2013. Receivables collected during the latest quarter will exceed $300,000 compared to $42,229 for the previous quarter and the consolidated cash balances are $125,000 compared to $-0- for the June quarter. Net Income and earnings per share are subject to further review to comply with generally accepted accounting principals and were not available at the time of the release.

“The Company is working hard to become more transparent and efficient in reporting financial results and activities,” states Artemus Mayor, President of the Company. “Our results for the quarter are within our expectations and we are pleased with the positive cash flow that the Company has now begun to enjoy,” Mr. Mayor continued, “All of our subsidiaries, BBORL, Inc, Sovereign International, Inc., Medical Greens, Inc and SK3 Services, Inc., contributed during the quarter.”

The Company will file the financial statements and footnotes along with its quarterly report as soon as it receives final clearance from all required parties, and expects to do so well in advance of normal filing date.

Finally, the Company will conduct a closed conference call similar to the one held in September with its officers and directors. The Company expects to post that conference call on its web-site, www.medicalgreens.com, on November 5, 2013.

About SK3
SK3 Group, Inc. is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 Group, Inc. brings standardization and transparency to this rapidly growing segment of the alternative care field.

Investor Relations
investors@medicalgreens.com
Or call 855-868-7577 (Dial 1 for direct IR)
SKTO's Medical Greens Announces a New Product Line to Market Through Contracted Collectives
Sk3 Group, Inc. October 17, 2013 at 01:11 PM
SKTO's Medical Greens Announces a New Product Line to Market Through Contracted Collectives

LOS ANGELES, CA, Oct 17, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc.'s (otc pink:SKTO) (the "Company") Medical Greens announces the development of a new delivery system for large doses of phyto-cannabinoids, as used in the "Simpson" therapy, and a new licensed product line utilizing this delivery system. Medical Greens will now license the Canna-Loz(TM) products to be available through collectives managed by or partnered with Medical Greens.

Canna-Loz(TM) is a soft lozenge containing 250 mg. of whole-plant cannabis extract oil, with approximately 50% cannabinoids, mainly THC and CBD, but with all of the lesser cannabinoids, as well as the entire array of terpenes and terpenoids.

Known as Organakoil, this extract has been available to patients for two years through the Dharma Care and Hospice Program. Utilizing the licensed Canna-Loz(TM) as the delivery system will make the therapy far easier and more palatable then the current delivery methods. Canna-Loz(TM) was developed as a delivery system that facilitates so-called "Simpson" therapy in the treatment of serious diseases, without the considerable discomfort of administration in the manner recommended by Mr. Rick Simpson in his "Run From the Cure" video on YouTube (www.youtube.com/watch?feature=player_embedded&v=LP35rQaq8-M). The standard recommended practice is to rub a "tic-tac"-sized bead of oil on the gums until one gram of oil is consumed daily, a messy and ill-tasting practice, which can leave the mouth and teeth green, and has proven to be difficult for some patients.

Under the license granted by Medical Greens, the concentrates are prepared using 190 proof ethanol (drinking alcohol) that has been certified organic. This extracting agent is used because it captures the widest spectrum of the medicinal elements found in the cannabis plant and is also the healthiest agent that can be used in this type of extraction.

A patient utilizing "Simpson" therapy can chew four Canna-Loz(TM) daily and receive the full one-gram dose recommended in "Simpson" therapy. Slices of the Canna-Loz(TM) can be placed between the gum and cheek for smaller doses, and the physical act of consuming the medicine is made far more pleasant.

"The Canna-Loz(TM) medicinalizes the rather messy process of taking the large doses of cannabis oil necessary for 'Simpson' therapy rather nicely," said Mary Ann Harrel Hoye, developer of the lozenge delivery system for Berkeley Bio-organic Research Laboratories. While this version is meant for high-THC cannabis oil therapy, we are excited about utilizing the lozenge for delivery of larger doses of our non-psychoactive phyto-cannabinoid newly licensed product line, Dharmanol(TM) in the near future.

Mr. Artemus Mayor, President of Medical Greens said, "We are excited about this new licensing opportunity and the other new product licenses that we have been able to obtain recently. Canna-Loz(TM) will further enhance our collectives' product lines and therefore more revenue centers for the collectives managed by the Company."

Canna-Loz(TM) is part of the licensed YAK line of medicinal cannabis edibles and will be available through the collectives and dispensaries managed by or partnered with Medical Greens. The license suggested retail pricing for Canna-Loz(TM) will be discussed during the Company's recorded conference call planned by the end of the month.

FDA Disclaimer These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease. Use only as directed.

About SK3 Group, Inc.
SK3 Group, Inc. is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, the Company brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SKTO Announces Third Quarter Report Date and Conference Call and Milestones
Sk3 Group, Inc. October 11, 2013 at 12:00 PM
SKTO Announces Third Quarter Report Date and Conference Call and Milestones

LOS ANGELES, CA--(Marketwired - Oct 11, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) ("the Company") announced that it plans to release 3rd quarter results by month's end.

As part of the Company's effort to enhance its operations, management is improving its reporting efforts and as a result will issue the 3rd quarter results early. "We are continuing to bolster our managerial services and as a result we will be better able to report to our shareholders results of operations for the 3rd quarter and 9 months ending September 30, 2013, earlier than required," stated Mr. Artemus Mayor, President of SK3 Group, Inc. "We will also post to our web-site a pre-recorded conference call with the officers of the Company shortly after the reporting of our 3rd quarter fiscal results," Mr. Mayor added. "While we had said before we may do a management conference call earlier in the month, we think it prudent to wait until after we have released the financials so that management can better respond to that information and any investor questions relating thereto."

For the near term, the Company's milestones include increasing revenues, steadily collecting receivables, expanding product offerings, enhancing the team and its capabilities, and cleaning up various corporate issues such as the CUSIP, dividend, name change, audits, and other operational issues.

"The Company had a terrific third quarter and when the financial results are released investors will see that we have continued in our long term focus to collect receivables and enhance revenues, increase cash on hand while investing intelligently in the business, focus on personnel and acquiring the right business relationships, and otherwise expand the Company's role in the medical marijuana space," said Kevin Allyn, the Company's Chairman. "We are looking forward to sharing more details with our investors on each of these points in the near future. But investors will be able to measure our long term progress by how we fare against our milestones."

Previously the Company announced, that its wholly owned subsidiary Medical Greens announced that it has obtained the exclusive license for Dharmanol? for the State of California. Dr. Charles Apel, of Berkeley Bio-Organic Research Laboratories has developed a proprietary technology to extract, stabilize, and preserve the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. This technology allows patients to consume cannabinoid medicine without any of the "high" or "stoned" effects.

Dharmanol? (pronounced DAR-mah-nol) will be available in two forms: low-dose non-psychoactive tablets and high-doses. The low-dose non-psychoactive tablets can be taken daily as a nutritional supplement to stimulate the endo-cannabinoid system, an internal system which controls and regulates many other bodily systems such as immune response. Much research has shown that there is substantial medicinal benefit in "stimulating" a compromised endo-cannabinoid system with cannabinoids, causing the other systems to work as they should.

The Company reserves the right to modify or amend its milestones at any time in response to business issues or for any other reason.

About SK3 Group, Inc.
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date

FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease. Use only as directed.

SKTO's Medical Greens Announces Licensing Agreement for Revolutionary New High Dose MMJ Delivery Option Dharmanol(TM)
Sk3 Group, Inc. October 10, 2013 at 12:00 PM
SKTO's Medical Greens Announces Licensing Agreement for Revolutionary New High Dose MMJ Delivery Option Dharmanol(TM)

LOS ANGELES, CA--(Marketwired - Oct 10, 2013) - SK3 Group, Inc.'s (OTC Pink: SKTO) subsidiary, Medical Greens, is pleased to announce that it has obtained the exclusive license for Dharmanol? for the State of California. Dr. Charles Apel of Berkeley Bio-Organic Research Laboratories has developed a proprietary technology to extract, stabilize, and preserve the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. This technology allows patients to consume cannabinoid medicine without any of the "high" or "stoned" effects.?

"We consider this to be a major breakthrough in the treatment of cancer using cannabinoids. The results seen by those groups and individuals promoting the use of what has been dubbed 'Simpson' therapy have been very convincing. The problem, however, has been that many people who are fighting cancer, and have no experience with cannabis, cannot take the emotional and mental effects that come from following the regimen, which requires consumption of a gram of cannabis extract oil every day for several months. This is the equivalent of smoking up to 100 marijuana cigarettes every day. The "high" from the experience is truly overwhelming, and we have seen patients choose to discontinue the therapy, even though doing so likely leads to negative effects on their treatment," said D. Gold, Dr. Apel's partner in development of the process. "Now patients will be able to consume the large doses necessary for this therapy to be effective, with none of the psychoactive side effects that have been such an unforgiving part of the therapy."

Dharmanol? (pronounced DAR-mah-nol) will be available in two forms: low-dose non-psychoactive tablets and high-doses. The low-dose non-psychoactive tablets can be taken daily as a nutritional supplement to stimulate the endo-cannabinoid system, an internal system which controls and regulates many other bodily systems such as immune response.?Much research has shown that there is substantial medicinal benefit in "stimulating" a compromised endo-cannabinoid system with cannabinoids, causing the other systems to work as they should.

These tablets will contain an array of the most beneficial non-psychoactive cannabinoids.?Each tablet will contain 5 mg. of CBD, 5 mg. of mixed cannabinoids in their non-psychoactive form (known as mixed carboxylates) and 5 mg. of a steam-distilled mixture of the natural terpenes and terpenoids found in cannabis and hemp. The terpene element is thought to be responsible for the increased medicinal efficacy of "whole plant" cannabis preparations.

At the opposite end of the spectrum is using high dosage Dharmanol? much like the "Simpson" therapy. High doses can be taken daily with no psychoactive effects. On observing the positive results that patients are receiving with standard Simpson therapy, most people studying cannabis medicine agree that if the dose could be increased ten or a hundred times, its already substantial efficacy against cancer will be similarly enhanced. Now this is possible thanks to the removal of the "high" from the cannabinoids in the production of Dharmanol?.

"We believe that we have crossed the bridge, so to speak, between the incredible medicinal efficacy of the cannabis plant and the world of nutraceutical supplements. Now people will be able to benefit from the substantial health-giving aspects of the cannabis plant, without the 'high' and related side effects that have kept this wonderful herb from entering the world of mainstream medicine. Dr. Apel and I would like to thank all those who have worked so hard on this project to help us develop this new technology," said Gold.

"We are pleased to have acquired this exclusive license to this important new product in the fight against disease using medical cannabis," said Artemus Mayor, President of SK3 Group. "We expect it to be in high demand with collectives and consumers."

Dharmanol? tablets will be distributed through the collectives managed by or partnered with Medical Greens, which currently has products in over 75 collectives in the state of California.?The Manufacturer's Suggested Retail Price will be $25.00 per bottle for 8 capsules.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.?Use only as directed.

SK3 Group, Inc. Announces Change to Conference Call Dates, Clarifies New Address
Sk3 Group, Inc. September 06, 2013 at 07:00 PM
SK3 Group, Inc. Announces Change to Conference Call Dates, Clarifies New Address
LOS ANGELES, CA, Sep 06, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc.'s (OTC Pink: SKTO) (the "Company") Investor Relations firm, Rubicon Capital Advisors, on behalf of the Company advises its shareholders today that the planned investor conference call scheduled for the week of September 6, 2013 has been delayed due to the enormous response from shareholders and interested parties. Over 100 questions were presented to the Company's executive team and board of directors. As a result, the Company did not have enough time, due to the Labor Day shortened week and the religious holiday, to properly prepare the question and answer forum. Therefore, the pre-recorded conference call will be available to the investing public no later than Thursday, September 12, 2013 and will be posted on the Company web-site, www.medicalgreens.com.

On August 30, 2013, the Company had issued a press release with an address change. There was some confusion as to the actual corporate headquarters and the city in location in California. The announced address currently houses our technical operations and the address below is our new corporate headquarters.

448 S. Hill St., Suite 405 Los Angeles CA 90013

About SK3 Group, Inc.
SK3 Group, Inc. is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to the rapidly growing alternative care field.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.
SKTO Applauds New Justice Department Guidelines on Marijuana Operation Prosecutions
Sk3 Group, Inc. August 30, 2013 at 06:55 AM
SKTO Applauds New Justice Department Guidelines on Marijuana Operation Prosecutions
IRVINE, CA, Aug 30, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc. (PINKSHEETS: SKTO) ("the Company") applauds the announcement today from the US Department of Justice ("DOJ") that it will exercise its enforcement powers under the Controlled Substances Act, and its criminal investigation and enforcement powers and its civil enforcement powers, with respect to those states where marijuana activity is being regulated by state authorities with constraint to certain well thought out principles. The complete text of the DOJ release can be found here:

http://www.justice.gov/opa/pr/2013/August/13-opa-974.html

and the complete text of the specific memorandum issued to prosecutors can be found here:

http://www.justice.gov/iso/opa/resources/3052013829132756857467.pdf

This announcement follows on the heels of President Obama announcing this past December that it does not make sense for the federal government to go after recreational drug users in a state that has legalized recreational use of small amounts of marijuana, and after numerous survey results in the past six months showing that a majority of the American public favors legalization of use in some form. It comes within weeks of the CNN broadcast of Dr. Sanjay Gupta's enlightening documentary on the same subject.

Under the new DOJ approach, the size of the "marijuana operation" relating to marijuana will no longer be determinative, by itself, of a government decision to investigate or prosecute, but rather just one factor to consider along with among other things whether a "marijuana operation" is in compliance with a strong and effective state regulatory system.

"This sea change in approach reflects true leadership by the DOJ and bodes well for the growth of the medical marijuana industry in California and elsewhere," said Company Chairman Kevin Allyn. "Now, if they obey the state regulatory requirements, collectives, for their patients, can focus on acquiring the quality products they need to maintain their patients' quality of life without the fear of federal intervention that used characterize their business life. We salute the Obama administration in this forward and practical approach to one of the fastest growing regulated businesses in the United States."

About SK3 Group, Inc.
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date
SKTO Announces New Company Address in California and Conference Call Details Update Updated address: 3300 Irvine Ave., Newport Beach, CA 92660
Sk3 Group, Inc. August 30, 2013 at 06:54 AM
SKTO Announces New Company Address in California and Conference Call Details
IRVINE, CA, Aug 30, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc. (PINKSHEETS: SKTO) ("the Company") has announced that it is moving its headquarters to Irvine, California. The new address will be:
Medical Greens 3300 Irvine Blvd., Ste. 200 Irvine, CA 92604

We ask that you please continue to reach out to our investor relations firm, Rubicon Capital Advisors LLC, with any questions, comments, or requests for information.

The Company also has announced that it will conduct a recorded conference call that will be available to its shareholders on the Company's website next week featuring Company Chairman Kevin Allyn and General Counsel Jeff Benz answering questions. If you have any questions you would like to have answered, please forward them to Rubicon at joanne@rubiconcapitaladvisors.com by Friday at 5pm PT. While they will endeavor to answer the most significant questions, they will not be able to answer all for a variety of reasons, including time constraints, limitations on confidential information disclosure, and public capital markets regulations, but they will provide an update on the Company. The Company will provide exact information on the posting of this call when it becomes available shortly.

About SK3 Group, Inc.
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.
SK3 Group Distribution of SKTO Products Growing
Sk3 Group, Inc. August 27, 2013 at 08:38 AM
SK3 Group Distribution of SKTO Products Growing
MIAMI, FL, Aug 27, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc. (PINKSHEETS: SKTO) ("the Company") has announced that its licensed products are seeing wide distribution across California. As of July 2013, the Company's recipes and brands can be found in over 58 medical cannabis dispensaries throughout California. Some of these products include Yak Whole Plant Extract Capsules in Indica, Sativa and High CBD, which contain the non-psychoactive cannabinoid cannabidiol, Yak Haute Chocolate instant chocolate drink, Yak Mocha-Juana instant chocolate & coffee drink, Yak Greenie Whole Plant Extract Cookie, Yeti Premium Preroll for powerful pain relief which contains high-quality cannabis flowers impregnated with potent Red Diamond oil, and Organakoil whole plant extract which is used for the "Simpson Treatment." The Company is undertaking strategies to ensure that the number of retail points selling these licensed products continues to grow aggressively in the coming months.

A. Mayer, President SK3 Group, said, " Mass distribution in the States that are now selling medical cannabis is the key to the growth of the company and ultimately the revenue and we feel we are making great strides toward that end."

About SK3 Group, Inc.
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.
SK3 Group Announces New Dedicated Investor Relation Contacts, Comments on AEGY Distribution
Sk3 Group, Inc. August 26, 2013 at 03:26 PM
SK3 Group Announces New Dedicated Investor Relation Contacts, Comments on AEGY Distribution
MIAMI, FL, Aug 26, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc. (PINKSHEETS: SKTO) announces that its Investor relations consultant, Rubicon Capital Advisors has completed a dedicated web, phone and email presence for SKTO shareholder information. The new telephone # is 855-868-7577 (Dial 1 for direct IR) "Having a dedicated team addressing all our shareholder inquiries will assist in allowing our team execute on the day-to-day value actions, however we will be in close contact on all matters related to investor and shareholder relations. We would ask at this time that shareholders only use this telephone number and email, again allowing our team to concentrate on bringing value to our core business," comments Mr. A Mayor, President, SK3 Group.

Additionally, SK3 is still preparing for the distribution of the stock held in Alternative Energy Partners, which is expected be completed very soon. As was previously announced, this distribution of stock to the shareholders required that the shares be registered with the SEC before the distribution, a process which AEGY has agreed to undertake. This registration is a complex, expensive and time-consuming process and requires the completion of SEC review after filing, and the clearance of a Notice of Corporate Action filed with FINRA before it is effective. We are advised that AEGY will have the registration statement filed shortly, although an audit of its financial statements for its fiscal year ended July 31, 2013, must be completed before filing. Frequent updates will be made available as to the audit completion and effectiveness of the S1 in real time as The Company receives the latest information.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.
SKTO Announces Acquisition of Accomplished Medical Cannabis Consulting Firm
Sk3 Group, Inc. August 16, 2013 at 11:29 AM
SKTO Announces Acquisition of Accomplished Medical Cannabis Consulting Firm

Aug 16, 2013 (ACCESSWIRE via COMTEX) -- MIAMI, FL --(Accesswire - August16, 2013) - SK3 Group, Inc. (otc pink:SKTO) (SK3) announces that it has signed a definitive agreement to acquire Sovereign International, Inc., a full service medical cannabis consulting firm specializing in advising on cultivation techniques. Through a unique cultivation technique, including locating but not tampering with the genetics of the first generation OG Kush strain, Sovereign has played a vital role in building the household strain name "Sovereign OG." Sovereign has perfected this particular strain to have some of the most potent medicinal benefits for a wide range of ailments the symptoms for which research has shown will be alleviated by medical marijuana. Sovereign has worked with over 300 collectives in Southern California with some of the most discerning connoisseurs and a wide range of members that prefer, and are loyal consumers of, the "Sovereign OG" brand.

SK3 also announced it has filed a notice of late filing of its quarterly financial reports with OTC Markets and will file its second quarter financials next week.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SK3 Group Secures CBD Extraction and Purification Technology License
Sk3 Group, Inc. July 29, 2013 at 07:11 PM
SK3 Group Secures CBD Extraction and Purification Technology License

MIAMI, FL--(Marketwired - Jul 29, 2013) - SK3 Group, Inc. (PINKSHEETS:SKTO) announces that it has obtained licenses for several proprietary technologies for the extraction, purification, and creation of medicines consisting of cannabinoids from hemp and marijuana.

Cannabinoids are a natural substance with medicinal benefits found in cannabis. The most well-known is tetrahydrocannabinol, or THC. THC is responsible for the physical and mental effects (the "high") associated with smoking marijuana. Other cannabinoids (there are over 60 in the plant) such as cannabidiol (CBD) have been shown to have substantial medicinal value while producing no noticeable psychoactive effects. Production of medicines utilizing the non-psychoactive cannabinoids is the focus of these technologies. These technologies facilitate the preparation of cannabinoid medicines using techniques that will permit the safe and efficient preparation of several standardized cannabinoid medicines by the collectives managed by Medical Greens. Medical Greens will serve as lead consultant to the collectives, providing the technology necessary for the collectives to produce medicinal products from hemp or cannabis.

The medicinal products covered by this license include: High-CBD cannabis tinctures, capsules and edibles, a sublingual spray, and infused vegetable oils. Medical Greens will oversee quality control and provide testing for cannabinoid content and microbiological purity.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SK3 Group, Inc. Retains Research and IR Firm Rubicon Capital Advisors
Sk3 Group, Inc. July 24, 2013 at 11:51 AM
SK3 Group, Inc. Retains Research and IR Firm Rubicon Capital Advisors

MIAMI, FL--(Marketwired - Jul 24, 2013) - SK3 Group, Inc. (SKTO) announced today that it has engaged the International firm Rubicon Capital Advisors LLC to advise SK3 and its subsidiary, Medical Greens, Inc. on all matters concerning shareholder and investor awareness for a period of 6 months. Rubicon specializes in overseeing the investor relations for micro-mid cap listed entities looking to raise capital in alternative markets. Rubicon's CEO said, "It has been with great interest that we have followed the SKTO story and feel that our expertise and proper timing can bring enormous, long-term shareholder value in the weeks and months to come." "We are pleased to have them join us at this juncture. They are an experienced investor relations firm and we are lucky to have them aboard as we continue to build out our operations and reach," said Jeffrey Benz, General Counsel and Executive Vice President of Business, Legal, and Government Affairs.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field. For more please visit
www.medicalgreens.com

About Rubicon Capital Advisors

Rubicon Capital Advisors was founded and is managed by a team that has been actively involved in the financial research and investor relations industry for over 18 years and whose principles have distinguished careers in each of the sectors its covers. For more on Rubicon, visit: www.rubiconcapitaladvisors.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

AEGY Appoints Chief Technology Officer
AEGY July 08, 2013 at 03:08 PM
AEGY Appoints Chief Technology Officer

Boca Raton, FL, July 8, 2013 – (eTeligis via Accesswire) – Alternative Energy Partners, Inc. (AEGY) today announces that it has appointed Frank Gomez as its Chief Technology Officer.

Mr. Gomez was CTO/CCO for Kush Magazine and also part of the WeedMaps.com team during inception. Mr. Gomez is currently the CTO/CCO for Swissloan and CEO of Source Enterprises. Mr. Gomez has been brought on to AEGY to oversee the completion and launch of PharmaJanes[TM] and Simple Prepay[TM].

PharmaJanes[TM] is an on-line and smart phone ordering platform allowing medical marijuana patients to order, process, and pay for their authorized needs, in a simple, safe, and secure ordering and payment interface. Simple Prepay[TM] is a merchant payment solution developed to offer dispensaries, collectives, and delivery services of medical cannabis a convenient payment solution.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

SKTO Announces Auditor Engagement
Sk3 Group, Inc. June 27, 2013 at 07:03 AM
SKTO Announces Auditor Engagement

MIAMI, FL, Jun 27, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc. (OTC Pink: SKTO) announces that it has engaged the firm of L.L. Bradford Company, LLC to audit the financial statements of SKTO for the years ended 2010 through and 2012 and the current periods to date, and of its subsidiary, Medical Greens, Inc. through June 30, 2013. Audited financial statements are required for the pending registration statement for the merger of SKTO and Medical Greens announced last week, and the issuance of the new shares to be issued as a result of the merger.

L.L. Bradford is a PCAOB registered independent audit firm with offices in Las Vegas, Houston, Kansas and Southern California. SKTO has signed engagement letters for the respective audits and expect to start the audit process early next week.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SKTO Announces Merger Terms/Share Distribution
Sk3 Group, Inc. June 24, 2013 at 12:18 PM
SKTO Announces Merger Terms/Share Distribution

MIAMI, FL, Jun 24, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc. (OTC Pink: SKTO) announces that the previously reported merger of the company into its wholly-owned subsidiary, that was approved by the Board of Directors of the company, will result in the SKTO shareholders receiving three shares of Medical Greens, Inc. ("Medical Greens") common shares for each common share of SKTO held. The Medical Greens shares to be issued in the merger will be registered with the SEC and applicable state securities regulators. The parent-subsidiary merger was approved by the Board of Directors and does not require shareholder approval under state law. Medical Greens will be the surviving entity in the merger and as part of the transaction will request a new trading symbol from FINRA and a new CUSIP number.

Under the terms of the merger, shareholders of SKTO will be required to turn in their certificates for SKTO common shares in order to receive a new certificate for Medical Greens common shares.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SKTO Announces Merger Approval, Name/CUSIP Change
Sk3 Group, Inc. June 20, 2013 at 09:15 AM
SKTO Announces Merger Approval, Name/CUSIP Change

Jun 20, 2013 (ACCESSWIRE via COMTEX) -- MIAMI, FL --June 20, 2013- SK3 Group, Inc. (OTC Pink: SKTO) announces that it will be merging into its California subsidiary Medical Greens, Inc ("Medical Greens") and will apply to have its newly re- issued common shares admitted for trading under the name Medical Greens, and with a new trading symbol, upon approval from FINRA. Shareholders of SKTO will be required to exchange their SKTO shares for new shares of Medical Greens, the survivor in the planned merger. Also, SKTO will be applying for a new ticker symbol and CUSIP to reflect the new corporate name. The company will register the shares to be issued in the merger.

The previously announced distribution of common shares of Alternative Energy Partners, Inc. held by the company, to its shareholders is still underway and awaiting the filing and effectiveness of a registration statement for the shares, to be filed by Alternative Energy Partners. The company is advised that the registration statement should be completed and filed next week by Alternative Energy Partners.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SKTO Chairman to Be on Nationwide Radio Show
Sk3 Group, Inc. June 14, 2013 at 09:58 AM
SKTO Chairman to Be on Nationwide Radio Show

MIAMI, FL--(Marketwired - Jun 14, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) announces that Kevin Allyn, Chairman of SK3 Group, will be interviewed on a nationwide radio show on Monday, June 17, 2013, discussing the medical marijuana market and Medical Greens™. For more information about this broadcast, please visit the Company web site at www.medicalgreens.com, on Sunday evening (June 16) after 6PM EDT, when the details of the broadcast will be available.

The scheduled interview on Monday is in addition to a pending interview by Larry King, which has already been announced on the Medical Greens web site.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SKTO Announces Record Date for Stock Dividend
Sk3 Group, Inc. May 29, 2013 at 10:11 AM
SKTO Announces Record Date for Stock Dividend

MIAMI, FL, May 29, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc. (OTC Pink: SKTO) today announces that it has set a firm record date of June 5, 2013 for the previously announced distribution to its shareholders of 100 million common shares of Alternative Energy Partners, Inc (OTCBB: AEGY). The AEGY common shares to be distributed to the SKTO shareholders will be registered with the SEC and applicable state securities regulators before the shares are distributed, and the AEGY shares will be fully registered, free-trading shares when distributed.

The registration statement for the shares is expected to be filed by AEGY next week, and should be effective within a few weeks thereafter. The shareholders of SKTO who will receive the AEGY common shares will be determined based on the shareholders of record of SKTO at June 5, 2013. The number of shares of common stock of AEGY to be distributed to each SKTO shareholder will be based on the total number of SKTO shares issued and outstanding at that record date, and the distribution will be made pro rata based on the applicable voting power of the outstanding SKTO stock.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SKTO Announces Stock Dividend of AEGY Shares
Sk3 Group, Inc. May 28, 2013 at 12:52 PM
SKTO Announces Stock Dividend of AEGY Shares

MIAMI, FL, May 28, 2013 (Marketwired via COMTEX) -- SK3 Group, Inc. (OTC Pink: SKTO) today announces that it will be distributing 100 million common shares of Alternative Energy Partners, Inc (OTCBB: AEGY) to its shareholders of record at the close of business on the date of filing of a registration statement to register the shares to be distributed. The AEGY shares which will be distributed represent the consideration SKTO will receive from AEGY for the recently granted exclusive marketing agreement under which AEGY will be the exclusive on-line and smart phone ordering platform for the medical marijuana collectives managed through SKTO. SKTO will receive the AEGY common shares as soon as AEGY has completed the amendment to its Articles of Incorporation to increase its authorized common shares, a process which is already underway.

The shares to be distributed to the SKTO shareholders must be registered with the SEC and applicable state securities regulators before the shares can be distributed, which is expected to take several weeks. The shareholders of SKTO who will receive the AEGY common shares will be determined based on the shareholders of record of SKTO at the date the registration statement is first filed with the SEC, and will take place as soon as that registration statement is declared effective. The number of shares of common stock of AEGY to be distributed to each SKTO shareholder will be based on the total number of SKTO shares issued and outstanding at the record date, and the distribution will be made pro rata based on the applicable voting power of the outstanding SKTO stock.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SKTO Secures Additional Acres for the Cultivation of Medical Marijuana
Sk3 Group, Inc. May 20, 2013 at 09:21 AM
SKTO Secures Additional Acres for the Cultivation of Medical Marijuana

LOS ANGELES, CA--(Marketwired - May 20, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) announces that it has secured an additional 10 acres of real estate in Northern California to develop and manage state-of-the-art growing facilities for its member collectives. A portion of the newly secured land has been engaged in the legal cultivation of medicinal marijuana for a number of years, specializing in the development of high-CBD strains, and certain strains specifically designed for the new non-psychoactive cannabis-based medicinal marijuana being developed for the pharmaceutical market.

Over the past two months, SK3 Group, Inc has secured an aggregate of over 50 acres of land for medical marijuana cultivation. The land secured by SK3 Group will enable the collectives to maintain a perpetual harvest year round. Part of the fertilizer / nutrient needs for this new facility will be supplied by the byproducts of the Southern California facilities, which incorporate aquaculture with hydroponics. The newer land acquisition in Northern California utilizes several proprietary technologies to produce the finest medicine year round, in a very energy-efficient manner. The facility combines greenhouse growing with HID and LED enhancement, photoperiod control via light deprivation, growth acceleration by C02 enhancement (utilizing captured CO2), and hydroponic growing techniques utilizing organic nutrients and enzyme teas.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

AEGY Announces Acquisition of Medical Cannabis Payment Solution
AEGY May 15, 2013 at 08:57 AM
AEGY Announces Acquisition of Medical Cannabis Payment Solution

LOS ANGELES, May 15, 2013 -- Alternative Energy Partners, Inc. (AEGY) announces that it has signed a definitive agreement to acquire the Simple Prepay™ merchant payment solution from iEquity Corp. The Simple Prepay™ system was developed to offer dispensaries, collectives, and delivery services a secure and convenient payment solution for medical cannabis. Medical marijuana patients will be able to upload funds onto their Simple Prepay™ account via a smart phone application or website, allowing them to purchase their medical cannabis needs with privacy and simplicity.

Combined with the PharmaJanes™ on-line and smart phone ordering platform, which AEGY also is acquiring, medical marijuana patients will be able to order, process and pay for their authorized needs through a simple, safe and secure ordering and payment interface. Local licensed collectives or other licensed medical marijuana providers in the home state of the end-user, will then fulfill the orders provided through this new system, in full compliance with state and local laws and ordinances.

PharmaJanes™ will act solely as an expediter and processor of the authorized orders, and Simple Prepay™ will provide the secure payment platform, while the actual fulfillment function will be done entirely within the particular state of residence of the purchaser, by a locally licensed and regulated independent medical marijuana provider.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

AEGY Announces Acquisition of Medical Cannabis Marketing Company
AEGY May 14, 2013 at 11:09 AM
AEGY Announces Acquisition of Medical Cannabis Marketing Company

LOS ANGELES, May 14, 2013 -- Alternative Energy Partners, Inc. announces that it has signed a definitive agreement to acquire the PharmaJanes(TM) marketing operation from iEquity Corp. and will be changing its business model to focus purely in the medical marijuana marketing space. AEGY will be changing its name to PharmaJanes, Inc and will no longer move forward with the previously announced 1:100 reverse split.

PharmaJanes(TM) is currently developing a web and phone application that allows individuals to place orders for medical marijuana through a website and smart phone application anywhere such a transaction is legal in the United States. The purpose of PharmaJanes(TM) is to give patients a simple ordering platform, while allowing local collectives to service the orders in compliance with state and local laws and ordinances. PharmaJanes(TM) will act solely as an expediter and processor of the orders, and the fulfillment function will be done entirely within the particular state of residence of the purchaser, by licensed collectives or other licensed medical marijuana providers in that state

PharmaJanes(TM) currently has over $5M in annual marketing contracts in place for this service and will be the exclusive point-of-sale interface for the collectives under contract.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

SK3 Group to Acquire Major Medical Cannabis Research Firm
Sk3 Group, Inc. April 29, 2013 at 07:22 AM
SK3 Group to Acquire Major Medical Cannabis Research Firm

MIAMI, FL--(Marketwired - Apr 29, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) announces today that it has signed a definitive agreement to acquire Berkeley Bio-Organic Research Laboratories, a firm devoted to developing the pure science of cannabis medicine. Berkeley Bio-Organic Research Laboratory ("Berkeley Bio") was formed as a partnership in 2011 by Dr. Charles Apel, Ph.D. and David Hoye, who has been a well-known cannabis researcher and author since the early 1970's under the pseudonym "D. Gold."

While the firm itself is new, Mr. Hoye and Dr. Apel began working together about forty years ago when Dr. Apel helped Hoye develop the methods in Hoye's book, D. Gold; Cannabis Alchemy, Methods for Preparation of Extremely Potent Cannabis Products in 1972. The book, still in print and available on amazon.com among other outlets, has sold over 100,000 copies over the years and is recognized as the standard work on cannabis extraction and concentration. It was the first book published to present cannabis technology from a consumer's point of view.

Hoye went on, through numerous books, products and inventions, to become an authority and household name, again as D. Gold, in the world of scientific cannabis culture and technology. He opened the first new legal dispensary in San Francisco in 1996 after the passage of prop. 215, and founded the Dharma Patients Cooperative non-profit (now Dharma Care and Hospice Program) in 2006, which supplies free medicine to terminal hospice patients in California who have been recommended cannabis medicine by their doctor, but cannot afford it.. Recently Hoye penned the soon-to-be-published, Cannabis Chemotherapy, a compendium of scientific literature demonstrating the efficacy of concentrated cannabis medicine in treating cancer.

Dr. Apel has devoted much of his life to pure science, obtaining his PH. D in chemistry from University of California. Dr. Apel then conducted original research which showed that life on earth originated from freshwater ponds struck by lightning, instead of crawling from the sea. Dr. Apel has presented his findings at major universities around the world. Dr. Apel is a Postdoctoral Fellow in the astrochemistry branch of the Space Science Division of NASA/Ames Research Center, a research scientist with SETI (Search for Extraterrestrial Intelligence), has served as a consultant to the Artificial Life Project at Los Alamos National Laboratory, a Lecturer in Biochemistry at San Jose State University, and is the Chief Science Officer at Berkeley Bio-Organic Research Laboratory. Dr. Apel is also an Associate Editor of Biosystems Journal.

The main concentration of Berkeley Bio is the development and production of non-psychoactive cannabinoid medicines, primarily for the treatment of cancer, allowing patients to obtain medically efficacious doses without attendant, and possibly negative, psychoactive consequences. A secondary interest is the development and production of equipment for the manufacture and production of cannabinoid-based medicines. Berkeley Bio has made substantial strides in these areas.

"We are pleased to have Berkeley Bio, Dr. Apel and David Hoye join the SK3 family," said A. Mayor, President of SK3 Group. "Our goal has been to assemble the finest minds on the planet to develop this venture. The team that SK3 Chairman Kevin Allyn has already assembled is first class, and with the addition of Dr. Apel, we have added a highly-respected scientist with a great mind and much knowledge in our area. David Hoye brings us a lifetime of experience in the world of cannabis, with many inventions and accomplishments. The acquisition of Berkeley Bio brings us a solid research laboratory to further our efforts to ensure that lawful consumers of cannabinoid medicines are able to have their medical needs met. We could not be more pleased and we look forward to a successful collaboration as we build this business."

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

SKTO Secures Over 40 Acres to Develop State-of-the-Art Growing Facilities
Sk3 Group, Inc. April 12, 2013 at 01:30 PM
SKTO Secures Over 40 Acres to Develop State-of-the-Art Growing Facilities

MIAMI, FL--(Marketwired - Apr 12, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) announced today that it has secured an aggregate of over 40 acres of real estate in Southern California to develop indoor and outdoor state-of-the-art growing facilities for the collectives it is managing. The real estate will enable the collectives to maintain a perpetual harvest all year long. The facilities will also feature eco-friendly recirculating aquaculture systems to grow quality farm raised fish and to provide an organic, self-contained, growth environment for medical cannabis. The aquaculture system will be used to grow and maintain the fish, capture the waste so there is no discharge into the environment, and then recycle the waste, capturing the resulting methane gas for heating, using the liquid for growing organic crops, and applying the remaining waste as fertilizer.

SK3 also reports that it has registered with the disclosure services of OTC Markets and is preparing its financial statements for calendar years 2011 and 2012 which will be filed along with the required company disclosures, to return it to full public information disclosure status. It is anticipated that the financial statements and company information with be filed next week.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SK3 Group, Inc. Bridges the Gap Between Collectives and Patients
Sk3 Group, Inc. April 04, 2013 at 07:31 AM
SK3 Group, Inc. Bridges the Gap Between Collectives and Patients

MIAMI, FL--(Marketwired - Apr 4, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) today announced that it has recently contracted over a dozen healthcare facilities and providers in Southern California to become their Medical Cannabis Administrator (MCA). "Medical marijuana eases the suffering of our patients," says Armen Kazanchian, M.D. Ph.D. "With our relationship with Medical Greens, we will be able to better administer this important treatment to our patients." SK3 indicates that it will continue to aggressively seek new contracts with medical facilities and providers throughout California.

About SK3 Group, Inc.
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

SKTO Signs Accomplished Legal Executive Jeff Benz
Sk3 Group, Inc. March 26, 2013 at 07:59 AM
SKTO Signs Accomplished Legal Executive Jeff Benz

MIAMI, FL--(Marketwire - Mar 26, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) today announces that it has appointed Jeffrey Benz, an experienced business attorney and former executive with various sports, entertainment, and technology companies, as General Counsel and Executive Vice President of Business, Legal, and Government Affairs.

"We are bringing together a management team with the unique and demonstrated abilities to drive our business to success," said Kevin Allyn, Chairman of SK3. "Jeff Benz has broad experience as a senior executive, lawyer, and entrepreneur in entertainment, sports, licensing, intellectual property, and technology. Jeff has been a trusted advisor to a variety of companies, both private and public, and has advised a number of high profile executives. Among other things, Mr. Benz was the General Counsel and head of business and government affairs for the United States Olympic Committee, AVP Pro Beach Volleyball Tour, and a variety of private companies in sports, entertainment (television, film, and online), and technology (mobile phone applications, computer software and hardware, and medical devices), and has lead high profile legal and operational functions in a wide array of industries, including internationally. Mr. Benz's extraordinary experience and background, and his legal leadership skills, uniquely fit our current needs and will lead SKTO into lucrative new markets."

Mr. Benz has BA and MBA degrees from the University of Michigan and a JD from the University of Texas. Mr. Benz is also an accomplished arbitrator and mediator, and has served as a private judge in, among other things, disputes over athlete doping issues in sports, having lead the anti-doping program at the USOC when he was there.

SK3 has shifted its business model to focus purely on the medical marijuana space. SK3 recently announced its acquisition of Medical Greens™, a business that currently provides licensing, management, and logistic services for Medical Marijuana collectives throughout California. In 2013 alone, Medical Greens™ has already contracted over $30 Million in licensing and service agreements. As part of the company repositioning, the Board of Directors will be announcing new officers and executives throughout the next quarter. Besides his leadership role, Benz will be assisting with the recruitment, sourcing, and documenting relationships with key executives, directors, and strategic partners, including those for SK3's newly acquired subsidiary, Medical Greens™.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SK3 Group, Inc. Announces $30 Million in New Contracts.
Sk3 Group, Inc. March 22, 2013 at 09:51 AM
SK3 Group, Inc. Announces $30 Million in New Contracts.

MIAMI, FL--(Marketwire - Mar 22, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) today announces that its newly acquired subsidiary, Medical Greens™, has contracted for over $30 Million in annual licensing, management, and logistic services from collectives throughout California, after only its first full week of operations under SK3 Group, Inc. "Our team has been exceptional in establishing new client relationships, as we have assembled a complete state-of-the-art service package for the collectives we will manage and consult," states Kevin Allyn, Chairman of SK3. "We have teamed up with top industry experts to offer the highest quality of service and experience for our clients. Currently, we are working with several additional collectives in transitioning their current services and operations into Medical Greens™."

Recently, SK3 announced that it has shifted its business model to focus purely on the medical marijuana space with the acquisition of Medical Greens™, a business that currently provides licensing, management, and logistic services for medical marijuana collectives throughout California.

About SK3 Group, Inc.
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

SKTO Announces New Chairman
Sk3 Group, Inc. March 13, 2013 at 03:15 PM
SKTO Announces New Chairman

MIAMI, FL--(Marketwire - Mar 13, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) today announces that it has appointed licensing expert and former Executive of King World Productions, Kevin Allyn, as Chairman of the Board of Directors.

"Each of the members voted onto the Board brings experience, a unique perspective and direction," said A. Mayor, CEO of SK3. "Kevin Allyn has broad experience as a senior executive and entrepreneur in entertainment, television, film, music, sports, licensing, and talent management. Kevin has also been an advisor to a variety of companies both private and multi-billion dollar public companies. Mr. Allyn was also one of the presidents of King World Productions, one of the most successful television companies in history. King World is the leading worldwide distributor of first-run programming, including the two highest-rated, first-run strips in syndication, WHEEL OF FORTUNE and JEOPARDY, as well as OPRAH, CSI, INSIDE EDITION, DR. PHIL, EVERYBODY LOVES RAYMOND, HOLLYWOOD SQUARES and THE LITTLE RASCALS. Mr. Allyn's legendary list of contacts, his ability to innovate and his management expertise allow us to form a team that can scale effectively into this lucrative market."

SK3 has shifted its business model to focus purely on the medical marijuana space. SK3 recently announced its acquisition of Medical Greens™, a business that currently provides licensing, management, and logistic services for Medical Marijuana collectives throughout California. In 2013 alone, Medical Greens™ has already contracted over $12.5 Million in licensing and service agreements.

As part of the company repositioning, the Board of Directors will be announcing new officers throughout the next quarter. Besides his leadership role, Allyn will be assisting with the recruitment of key executives and strategic partnerships, including those for SK3's newly acquired subsidiary, Medical Greens™.

About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

SK3 Group, Inc. Announces Acquisition of Medical Cannabis Company
Sk3 Group, Inc. March 11, 2013 at 02:59 PM
SK3 Group, Inc. Announces Acquisition of Medical Cannabis Company

MIAMI, FL--(Marketwire - Mar 11, 2013) - SK3 Group, Inc. ( OTC Pink : SKTO ) today announces that it has acquired Medical Greens ™ and has changed its business model to focus purely in the medical marijuana space. Medical Greens ™ currently provides licensing, management, and logistic services for Medical Marijuana collectives throughout California. In 2013 alone, Medical Greens ™ has already contracted over $12.5 Million in licensing and service agreements.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

Investors

iEquity is a privately held company and is currently closed to new investors. For future consideration, please feel free to send your contact details to INFO@IEQUITYCORP.COM

iEquity Corp © 2014